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length. 1 mm scale applies to all cross-sectional images and histology sections. ........................ 74
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Atherosclerosis is the major form of cardiovascular disease, which has been the number one
cause of death in the United States and worldwide for a century. Among the different plaque
types, vulnerable plaques account for the majority of fatal acute coronary syndromes due to their
rupture and thrombosis. Currently, there are no clinically available imaging tools to reliably and
accurately detect vulnerable plaques largely due to the lack of chemical selectivity. This gap,
along with the increasing prevalence of coronary artery diseases, highlight an unmet clinical
need for an imaging modality with both chemical selectivity and enough depth resolution to
advance the detection, understanding, and treatment of lipid-laden vulnerable plaques. During
the past decade, intravascular photoacoustic (IVPA) imaging has been demonstrated as a
promising approach to meet this pressing need. However, this research direction is confronted
with several significant bottlenecks, which have blocked this technology from in vivo
applications. Here, this dissertation work is devoted to addressing these bottlenecks and
translating this imaging technology towards clinical utility.
First, the lipid contrast in IVPA imaging has not been fully explored in this research field.
Thus, in Chapter 1, the contrast mechanism in vibration-based photoacoustic imaging was
revisited. The lipid-water contrast and optical windows for lipid imaging at 1.2 and 1.7 µm were
further validated on a theoretical basis. Second, the slow imaging speed at minute-level per
frame is a longstanding challenge in clinical translation of IVPA imaging, as the clinical utility
requires real-time video-rate speed to reduce the operation time and to suppress the motion
artifacts caused by cardiac pulsation in vivo. In Chapter 2, a first-generation high-speed IVPA
imaging system at 1.7 µm was demonstrated. Using KTP-based OPO as optical excitation source,
an imaging speed of 1 frame per second was achieved, which is nearly two orders of magnitude
faster than previously reported imaging speeds. In Chapter 4, a second-generation high-speed
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IVPA imaging system at 1.7 µm, capable of imaging at 25 frames per second in real-time display
mode was further presented. This unprecedented imaging speed was achieved by concurrent
innovations in optical excitation laser source, IVPA catheter design, real-time image processing
and display algorithms. Third, an IVPA catheter, which has high detection sensitivity, clinically
relevant size, and functional sheath material integrated is another great challenge in clinical
translation of IVPA imaging. To meet these requirements, three different catheter designs were
prototyped and evaluated in Chapter 2, Chapter 3, and Chapter 5, respectively. Through collinear
or quasi-collinear overlapping of the optical and acoustic paths in the catheter, we have
significantly improved the detection sensitivity and penetration depth (>5 mm) of IVPA imaging.
Through quantitative comparison of multiple sheath candidates, we identified an optically and
acoustically transparent sheath material and further integrated it onto IVPA catheter, making it
feasible for in vivo validation of IVPA imaging. Finally, with a portable and fully integrated
IVPA imaging system, IVPA imaging was successfully performed in vivo on both rabbit and
swine models in Chapter 5. In the end, an outlook of IVPA imaging is provided in Chapter 6.
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1. INTRODUCTION

, .1

Atherosclerosis

1.1.1

Atherosclerosis progression

Cardiovascular disease, currently the leading cause of death and illness in developed countries,
will soon become the pre-eminent health problem worldwide [1, 2]. Atherosclerosis, a major
form of cardiovascular disease characterized by the accumulation of lipids and fibrous elements
within the artery wall, constitutes the single most important contributor to this growing burden of
cardiovascular disease [3-5]. As atherosclerotic lesions progress within the artery wall, these
lesions have been further classified into different stages. Figure 1.1 shows the life history of a
typical atheroma [3]. In a normal human coronary artery, the artery wall has a typical trilaminar
structure: intimal layer, media layer, and adventitia layer. The intimal layer is mainly made up of
endothelial cells, which is in contact with the blood in the arterial lumen attached upon a
basement membrane. In human adults, this layer generally contains a smattering of smooth
muscle cells scattered within the intimal extracellular matrix. Compared to the intima layer, the
media has multiple layers of smooth muscle cells, which are more tightly packed and embedded
in a matrix rich in both elastin and collagen. The adventitia, the outermost layer of an artery, is
mainly made up of connective tissue and an external elastic membrane. In early-stage atheroma,
the accumulation of lipids and inflammatory cells, initiated by sub-endothelial accumulation of
“foam cells”, can be found within the intima layer. These components then lead to formation of a
lipid-rich core and the gradual remodeling of the artery wall in an outward direction to
accommodate the intima expansion. If the inflammation prevails and other risk factors persist,
the lipid core can continuously grow into large lipid-rich necrotic core. If the lipid core is
covered by a thick fibrous cap with a preserved lumen, then this plaque is characterized as a
stable plaque. Patients can live with stable plaques for years without any symptoms. But if the
lipid core is covered by a thin fibrous cap, then this lesion is susceptible to rupture, which is also
termed “vulnerable plaque”.
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Figure 1.1: Schematic of the life history of an atheroma. This figure is adapted with permission
from Ref. [3].

1.1.2

Vulnerable plaques

As a chronic progressive disease, not every stages and types of atherosclerotic plaque are lethal.
The rupture of vulnerable atherosclerotic plaque, with its vulnerability defined by the propensity
for the plaque to rupture, contributes to the majority of acute coronary syndromes and sudden
cardiac deaths [6, 7]. Despite the mechanism and prevalence of plaque vulnerability still under
investigation, the thin-capped fibroatheroma has been understood to be the most vulnerable
plaque type [6, 8]. Thin-capped fibroatheromas are grossly defined by hallmarks of a large lipidrich necrotic core, thin fibrous cap, increased inflammatory infiltrate, and positive vascular
remodeling [5, 7, 8]. The plaque rupture occurs where the cap is thinnest and most frequently at
cap shoulder region [9, 10]. Thinning of the fibrous cap is due to either loss of smooth muscle
cells or inflammatory infiltrate that secretes matrix metalloproteinases and degrades collagenrich cap matrix [9]. With plaque rupture, the thrombogenic contents of lipid-rich necrotic core
are released into the bloodstream, leading to thrombosis and acute coronary syndromes. In
addition, theses vulnerable plaques are often structurally non-obstructive to moderately
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obstructive, thus clinically unidentifiable by routine angiography and stress testing [7, 11, 12].
Therefore, accurate identification of vulnerable plaques through advanced imaging or detection
technology is necessary for diagnosis and treatment, either by interventional or preventive
methods.

1.2

Limitations of current intravascular imaging tools

This eminent need, along with the prevalence of coronary artery diseases, has accelerated the
development of various intravascular imaging technologies in the last two decades, including
intravascular ultrasound (IVUS), virtual-histology IVUS (VH-IVUS), intravascular optical
coherent tomography (OCT), and intravascular near-infrared spectroscopy (NIRS). Each of these
modalities has their own specific strengths and weaknesses. However, none have shown the
ability to detect vulnerable plaques accurately and reliably [13-15]. IVUS is the current standard
for intravascular imaging of coronary atherosclerosis. Pulsed acoustic waves are used to
interrogate the vessel wall followed by the detection of echo signals, providing the overall
morphology of vessel wall with ultrasonic resolution. This modality has been applied in the
clinic to quantify plaque burden, longitudinally monitor disease progression, and guide the stent
deployment. Nonetheless, it lacks chemical selectivity to identify plaque composition. As tissue
components are found to have different acoustic properties, virtual-histology IVUS was then
developed to differentiate plaque compositions (e.g. necrotic core, calcium, fibrous, and
fibrofatty) based on the radiofrequency analysis of echo signals [16]. However, there have been
questions raised about its scientific foundation and thorough validation [17, 18]. Intravascular
OCT, based on the detection of backscattered light, can accurately detect fibrous cap thickness
with micron-scale resolution [19, 20]. However, the optical scattering does not provide chemical
contrast. Furthermore, scattering caused by soft tissue limits the penetration depth at a superficial
layer (1-2 mm), even with the removal of luminal blood [19]. Such imaging depth is insufficient
to cover deeper layers, where lipid-rich necrotic cores are typically located. Intravascular NIRS
has been shown to reliably detect lipid-rich plaques via the analysis of optical reflection
absorption spectrum of the arterial wall [21, 22]. It has been introduced into the clinic as a
hybrid-modality product, NIRS/IVUS. However, NIRS lacks the imperative depth resolution to
quantify lipid core size and precise location. Instead, it yields a chemogram of lipids with a
rough lateral resolution (~1 mm). These limitations highlight an unmet clinical need for the

4
development of a chemically selective imaging modality with sufficient spatial and depth
resolution to advance the detection, understanding, and treatment of lipid-laden vulnerable
plaques.

1.3

Intravascular photoacoustic (IVPA) imaging

PA imaging fundamentally lies in the light-to-sound conversion, a phenomenon termed
“photoacoustic effect” and discovered by Alexander Bell in 1880 [23]. In PA imaging, a shortpulse laser is typically used to excite targeted chemicals. As photons propagate inside the tissue,
part of the photons is absorbed by molecules when the photon wavelength matches the transition
frequency between its ground state and excited state. If the absorbed energy is partially or
completely thermalized through either non-radiative relation or vibrational relaxation, it will
subsequently induce a local temperature rise and the thermalized energy will be effectively
converted into transient waves through thermo-elastic expansion. The transient waves propagate
inside tissue and can be further detected by an ultrasonic transducer or transducer array to
reconstruct an image that maps the distribution of targeted molecules in tissue. The optical
absorption provides rich contrasts in PA imaging both endogenously and exogenously. The
hybrid optical excitation and acoustic detection in PA imaging provide far greater penetration
depth (up to 7 cm [24]) than pure optical imaging methods, as acoustic scattering is orders of
magnitude weaker than optical scattering and the diffused photons contribute equally to PA
signal generation. Through specific implementations[25], these advantages render PA imaging a
competitive modality for clinical applications on biomarker-related diseases (e.g. tumor
angiogenesis, atherosclerosis, and melanoma cancer). Many excellent review articles provide
comprehensive insight into different aspects of the imaging technology, which including
technical advances [26-28], applicable contrast agents [29-31], and a variety of biomedical
applications [32-36].
This light-to-sound conversion process is theoretically described by equation, �? =
�Γ�C �, where �? is the initial pressure rise, � is a constant, Γ is the Gruneisen parameter of the
absorber quantifying the thermoelastic expansion efficiency, �C is the absorption coefficient of
the absorber, and � is the local photon fluence. Here, the Gruneisen parameter can be further
expressed as Γ = β�G H /�J , where β is the isobaric volume expansion coefficient, �G is the
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acoustic speed, and �J is the specific heat capacity. This equation indicates a 100% relative
sensitivity to variations in optical absorption in PA imaging, which means that a small
percentage change in optical absorption is reflected by the same percentage change in PA signal
amplitude. Therefore, selecting the optical excitation wavelength that matches the absorber’s
absorption peak can effectively maximize PA signal. This equation is also the foundation for
quantitative photoacoustic imaging [28], including calculating the contrast from absorber to
surrounding tissue components, quantifying the relative concentration of absorber, and
estimating parameters of physiological interest derived from absorber concentration.
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Figure 1.2: Principle of IVPA imaging.
IVPA imaging has been implemented into an intravascular catheter probe for the clinical
detection of atherosclerotic plaques. Figure 1.2 depicts the imaging principle of IVPA imaging.
Laser pulses are delivered and side-fired onto the artery wall through an optical fiber. The
generated acoustic waves are detected by a miniaturized single element ultrasound transducer.
By using the same transducer, a conventional IVUS signal can be obtained simultaneously. The
ultrasound transducer along with the optical fiber is housed in a miniaturized catheter with an
ideal diameter of ~1 mm for intravascular access. At each angular position, a depth-resolved PA
signal, termed “A-line”, is recorded by the catheter probe. This signal contains the information of
absorber location, which can be calculated by the time delay. By rotating the catheter at a
constant speed, a cross-sectional PA image of the artery wall can be reconstructed. By pulling
back the catheter during rotation, a three-dimensional imaging of the artery wall is also obtained.

6

Table 1.1: Comparison of IVPA/US imaging with major intravascular imaging modalities in
vulnerable plaque identification. +++, excellent. ++, good. +, poor. -, not currently possible. N/A,
not applicable. Data is derived from Ref. [15, 37, 38].
Technology

lntravascular
Ultrasound (IVUS)

Virtual HistologyIVUS

lntravascular
Optical Coherence
Tomography (OCT)

Near-infrared
Spectroscopy/lVUS
(NIRS/IVUS)

lntravascular
Photoacoustic/Ultra
sound (IVPA/US)

Contrast mechanism

Acoustic scattering

Acoustic spectrum

Optical scattering

Optical absorption

Photoacousitic effect

Lateral resolution (µm)

200-500

200-500

~10

1000

200-500

Axial resolution (µm)

100-200

150-250

20-40

N/A

100-200

Penetration (mm)

>5

>5

1-2

Unknown

~5

Positive remodeling

+++

+++

+++

+++

+

+++

+++

+

+

+++

Fibrous cap
Lipid core
Inflammation

+

++

Representative
image

As an emerging modality to overcome the abovementioned limitations, catheter-based
IVPA imaging provides optical absorption induced contrast at ultrasonic spatial resolution. Its
endogenous lipid-specific mapping is based on the photoacoustic (PA) effect, where overtone
absorption-induced thermalized energy is effectively converted into acoustic waves. Its imaging
depth has been shown to be around 5 mm, with the potential for even deeper imaging by fully
taking advantage of diffused photons and weak acoustic scattering. Such penetration depth is far
beyond the reach of pure optical imaging methods. Furthermore, IVUS is inherently compatible
with IVPA to obtain arterial morphology, as they share the same ultrasound transducer. In
addition, exogenous contrast agents could be developed and integrated to simultaneously target
inflammatory markers of vulnerable atherosclerotic plaques. Thus, by providing co-registered,
simultaneous and complementary information of the artery wall, IVPA/US imaging can pave the
foundation for advanced assessment of lipid-laden vulnerable plaques. The comparison with
major clinically used intravascular imaging modalities in vulnerable plaque identification is
shown in Table 1.1 (data in the table derived from [15, 37, 38]).
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1.4

Contrast mechanisms in IVPA imaging

1.4.1

Vibration-based photoacoustic imaging

Vibration-based PA imaging arising from molecular vibrational absorption as a novel contrast
mechanism in biological tissue further extends PA imaging domain [36, 39]. Figure 1.3 depicts
the photon energy transfer on a Jablonski energy diagram, illustrating the differences between
PA imaging and one-photon fluorescence imaging and the difference between electronic and
vibrational energy transfer in PA imaging. In one-photon fluorescence imaging, the majority of
absorbed energy goes through radiative relaxation with photons emitted at a longer wavelength,
whereas in PA imaging the majority of absorbed energy is thermalized through non-radiative
relaxation. Therefore, PA imaging is more sensitive for chromophore mapping (e.g. hemoglobin,
lipids, melanin, DNA-RNA, and cytochromes). These chromophores can be further separated
into two groups: one group absorbs UV-visible light via electronic transitions (e.g. hemoglobin,
melanin, cytochromes, and DNA-RNA), and the other group absorbs light ranging from nearinfrared to mid-infrared via vibrational transitions (e.g. lipids and water). Here, the molecular
vibrational transitions describe the periodic motion of atoms in a molecule with typical
frequencies ranging from 1012 to 1014 Hz. More specifically, the vibrational transition from � =
1 to � = 0 is called fundamental transition typically located in the mid-infrared range [40]. The
transitions from � = � to � = 0 with � > 1 transitions are termed “overtone” with its absorption
peaks located in the near-infrared range [40]. The molecular population in the � NO vibrationally
excited state relative to the ground state follows the Boltzmann’s distribution law as �Q I�? =
exp (−∆� I ��), where ∆� is the energy gap, � is the temperature, and � is the Boltzmann
constant. Thus, the Boltzmann distribution describes how the thermal energy is stored in
molecules. When the incident photon energy matches the transition frequency between the
ground state and a vibrationally excited state, the molecule absorbs the photon and jumps to the
excited state. The subsequent relaxation of the excited molecule to the ground state thermalizes
the energy and induce a local rise in temperature. When both thermal and stress confinements are
satisfied [41], the accumulated heat is subsequently released through a thermal-elastic expansion
in tissue, which generates acoustic waves detectable by an ultrasound transducer. Thus far,
vibration-based PA imaging has enabled the visualization of different molecules and chemical
components in biological tissue. CH2-rich lipids, CH3-rich collagen [42], O-H bond-rich water
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[43], nerve [44, 45], intramuscular fat [46], and neural white matter [47] have been reported
through various PA implementations.
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Figure 1.3: Jablonski diagram, illustrating the difference in photon energy transfer between onephoton fluorescence imaging and photoacoustic imaging, and the difference between electronic
absorption and vibrational absorption in photoacoustic imaging. NIR, near-infrared. MIR, midinfrared.

1.4.2

Contrast mechanism and optical windows for lipid imaging

PA imaging of lipids is based on the strong vibrational absorption of C-H bond, abundant in
lipids [48]. The vibrational transitions of C-H bond can be described by the anharmonicity theory.
The transition frequency for an overtone band (from � = 0 to � = � (� > 1)) has the following
relation with the fundamental transition (from � = 0 to � = 1), Ω = Ω? �−χΩ? (� + �H ), where
Ω? is the transition frequency of fundamental band, χ is the anharmonicity constant, and � =
2, 3, … representing the first, second, and other higher order overtones. These overtone
transitions and combinational transitions of C-H bond are well studied through vibrational
spectroscopy approaches (e.g. near-infrared spectroscopy) [40, 49] and reflected in the
absorption spectrum of lipids. Figure 1.4a presents the absorption coefficient of lipid,
hemoglobin, and water in 400-2000 nm wavelength range (adapted from [36]). As shown, lipid
has absorption peaks at around 1730 nm, 1210 nm, and 920 nm, which correspond to the first,
second, and third overtone bands, respectively. However, the absorption of hemoglobin
dominates in the range of 400-1100 nm and overwhelms the third and higher-order overtone
bands of C-H bond. For longer wavelengths in the range of 1100-2000 nm, the absorption of
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hemoglobin reduces significantly. Thus, two optical windows are identified for PA imaging of
lipid (highlighted in blue between 1100-1300 nm and 1650-1850 nm), where the absorption of
lipid is maximized yet water absorption is locally minimized. In particular, in the first optical
window, the hemoglobin absorption is close to one order of magnitude smaller than lipid
absorption. The whole blood in the second optical window exhibits almost the same absorption
spectrum as pure water, as water is the major content of whole blood [50]. Many PA
spectroscopic studies have confirmed the two windows for lipid detections within the arterial
wall [39, 51-54].
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Figure 1.4: Optical windows for PA imaging of lipids. (a) Absorption coefficient profiles of
oxygenated hemoglobin (HbO2), deoxygenated hemoglobin (Hb), lipid, and water in 200-2000
nm wavelength range. (b) PA spectra of oxygenated blood, olive oil and water in 1100-1800 nm
wavelength range. The data set highlights two optical windows (1100-1300 nm and 1650-1850
nm) for PA imaging of lipids in near-infrared region.
Notably, the absorption coefficient of lipid is only slightly larger than that of water in
both optical windows. Yet, the contrast between the generated PA signals can be reliably
observed and separated. This discrepancy between similar absorption coefficients but greatly
different generated signals can be realized by the following theoretical calculation [36]. In
equation �? = �Γ�C � , only Γ and �C are have absorber dependence in tissue. Thus, the PA
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contrast of fat to water can be expressed as �?__CN /�?_`CNab = (Γ�C ) ?__CN /(Γ�C )?_`CNab . Based
on the Gruneisen parameters and absorption coefficients of fat and water listed in Table 1.2, this
contrast is calculated in the range of 9.6-12.4 and 10.9-14.0 at 1210 and 1730 nm, respectively.
Such calculation is consistent with experimental observations. As an example, Fig. 1.4b shows
the PA spectra of olive oil, water and oxygenated blood in the range of 1100-1800 nm. The olive
oil has around one order of magnitude larger PA signal than water at 1210 and 1730 nm.
Collectively, these experimental results and theoretical calculations enable vibration-based PA
imaging as a valuable platform for selectively mapping of lipids in a complex tissue environment.
Compared with 1210 nm, 1730 nm is more favorable for IVPA imaging. The signal amplitude at
1730 nm is significantly larger attributed by stronger absorption at this wavelength. In addition,
the optical scattering caused by blood is significantly less at 1730 nm [50], providing the
opportunity for IVPA imaging without the need for luminal blood flushing. Notably, due to the
heavier mass of deuterium, the prominent overtone and combinational bands of D2O have their
corresponding peaks at wavelengths longer than 1800 nm. Thus, D2O can be used as acoustic
coupling medium for vibration-based PA imaging [54]. Particularly, it can be used to flush the
catheter head enclosed in catheter sheath to reduce the optical path in water or blood.
Table 1.2: Absorption coefficients and Gruneisen parameters of fat and water at 1210 and 1730
nm.
Tissue
constituent
Fat
Water

Tissue Parameter

1210 nm

1730 nm

µa (cm-1)
Γ
µa (cm-1)
Γ

1.65
0.7~0.9
1.00
0.12

10.5
0.7~0.9
5.63
0.12
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2. HIGH-SPEED INTRAVASCULAR PHOTOACOUSTIC IMAGING AT
1.7 MICRON WITH A KTP-BASED OPO

This work presented in this chapter was published in Biomedical Optics Express [55] (reprinted
with permission from Optical Society of America Publishing, copyright by 2015 Optical Society
of America).
Abstract: Lipid deposition inside the arterial wall is a hallmark of plaque vulnerability. Based
on overtone absorption of C-H bonds, intravascular photoacoustic (IVPA) catheter is a promising
technology for quantifying the amount of lipid and its spatial distribution inside the arterial wall.
Thus far, the clinical translation of IVPA technology is limited by its slow imaging speed due to
lack of a high-pulse-energy high-repetition-rate laser source for lipid-specific first overtone
excitation at 1.7 µm. Here, we demonstrate a potassium titanyl phosphate (KTP)-based optical
parametric oscillator with output pulse energy up to 2 mJ at a wavelength of 1724 nm and with a
repetition rate of 500 Hz. Using this laser and a ring-shape transducer, IVPA imaging at speed of
1 frame per sec was demonstrated. Performance of the IVPA imaging system’s resolution,
sensitivity, and specificity were characterized by carbon fiber and a lipid-mimicking phantom.
The clinical utility of this technology was further evaluated ex vivo in an excised atherosclerotic
human femoral artery with comparison to histology.

2.1

Introduction

The majority of fatal acute coronary syndromes are due to plaque rupture and thrombosis [3-5,
56]. Pathophysiological assessment of atherosclerotic lesions have demonstrated that lesions
more prone or “vulnerable” to rupture and thrombosis contain large lipid cores and are located in
areas of high shear stress within the coronary arterial wall [3, 10, 57]. Currently, no clinically
available imaging devices can reliably and accurately diagnose vulnerable plaques [13]. Imaging
modalities, which include magnetic resonance angiography, computed tomography angiography
and X-ray angiography are used primarily to image the encroachment of plaques on the artery
lumen, which is not always predictive of lipid core size or plaque vulnerability. Among the
current interventional imaging approaches, intravascular ultrasound (IVUS) lacks the chemical
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selectivity to determine the lipid-composition of the vessel wall [58], even for the most recently
demonstrated multi-frequency IVUS method [59]. The so-called “virtual histology” based on
IVUS image processing has been challenged [18]. Intravascular near infrared spectroscopy can
detect lipids in the vessel wall with high specificity, but doesn’t provide enough depth to
visualize its overall distribution in the artery [21, 60]. Intravascular optical coherence
tomography accurately detects the surface layer of arterial wall with micron-scale resolution, but
has neither sufficient imaging depth nor chemical selectivity to determine plaque composition
[61]. These limitations highlight an unmet clinical need for a novel intravascular imaging system
maintaining both chemical selectivity and depth resolution.
Catheter-based intravascular photoacoustic (IVPA) imaging is considered as a promising
modality to bridge the aforementioned gap. Combining nanosecond pulsed laser excitation with
ultrasonic detection, IVPA catheters map chemical compositions in the artery based on their
optical absorption. Photoacoustic (PA) imaging of lipid-rich plaques has been demonstrated
under different wavelengths [62-64]. As reported, the 1.2 and 1.7 µm spectral bands resonant
with the second and first overtone vibrations of the C-H bond and are suitable for IVPA imaging
of lipid-rich plaques [39, 65, 66]. Compared with 1.2 µm excitation, 1.7 µm is more favorable
for IVPA imaging due to the high absorption coefficient and less optical scattering by blood [65,
67, 68]. A few groups have demonstrated the feasibility of IVPA imaging of lipid-laden plaques
by excitation at 1.7 µm, even in the presence of blood [54, 65, 66]. More recently, the in vivo
feasibility test has been performed in animal models [69, 70]. However, the in vivo imaging
applications of IVPA technology is blocked by the slow imaging speed due to the lack of a highpulse-energy high-repetition-rate laser source for high-speed lipid-specific excitation at 1.7 µm.
The traditionally used optical parametric oscillator (OPO) lasers operate at 10-20 Hz repetition
rate. Such a low repetition rate translates to a cross-sectional imaging speed of 50 s per frame of
500 A-lines, which is marginally useful for clinical applications. Recently, Song and coworkers
demonstrated catheter-based high-speed PA imaging of phantoms containing perivascular fat
using a commercial 1-kHz OPO at the wavelength of 1.7 µm [71]. The low pulse energy (~30 µJ)
of commercial OPO lasers, however, makes it difficult to generate data from real vascular tissues.
Here, we demonstrate a potassium titanyl phosphate (KTP)-based OPO with a pulse
energy up to 2 mJ at a wavelength of 1724 nm and with a repetition rate of 500 Hz. Our laser
outputs stable pulses with pulse duration of 13.2 ns and pulse-to-pulse variation of 6.3%. To
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obtain such high pulse energy and high repetition rate, we adopted two KTP crystals cut with a
special angle and placed with adverse orientation to effectively minimize the walk-off effect.
With this laser, we successfully performed human artery imaging ex vivo with an imaging speed
as high as 1 frame per sec, which is about 50-fold faster than previously reported IVPA systems
at 1.7 µm excitation [65, 66, 72].

2.2

Methods and materials

2.2.1

KTP-based OPO laser

We designed and constructed the compatible KTP-based OPO with high pulse energy and high
repetition rate for the demanding need of high-speed IVPA imaging. A schematic diagram of the
OPO laser was shown in Fig. 2.1. Two fiber-coupled laser diodes (LDs) with a 30 W maximum
output power at 808 nm were used as the pump source. The pump light was coupled into both
sides of the laser crystal at the same time by two groups of 2:5 coupling lenses. A 0.3%-doped
composite Nd:YAG crystal (diameter, 4 mm; length, 40 mm) was used as the active medium.
Here, the long crystal was chosen to reduce the damage to the pump LDs caused by the
unabsorbed diode laser; while a composite Nd:YAG crystal with low doping was chosen to
reduce the thermal lens effect and achieve a high-quality beam for the original fundamental laser,
which helped to improve the conversion efficiency. This crystal had a 5 mm-long un-doped part
on both distal ends and had the distal surfaces antireflection (AR) coated at both 808 and 1064
nm. A plane-plane resonating cavity was adopted in the laser system, which included the
Nd:YAG crystal, mirrors M1 and M2, two fold mirrors, and an electro-optic (E-O) Q-switch
(light green color framed). The flat mirror M1 was high-reflection (HR) coated at 1064 nm. The
output mirror M2 was coated with a transmittance equivalent of 60% at 1064 nm. Two fold
mirrors were AR coated at 808 nm and HR coated at 1064 nm. The E-O Q-switch was composed
of a polarizer, a quarter-wave plate and a potassium dideuterium phosphate (KD*P) Pockels cell.
The pump had a pulse duration of 230 µs, which just closely matches the lifetime of the upper
laser level for an Nd:YAG crystal. At the cavity output, the 1064 nm beam with pulse energy of
11 mJ was obtained with good beam quality and then redirected to the OPO by reflective mirrors
M3 and M4 (both HR coated at 1064 nm). The OPO (light pink color framed) was composed of
flat mirrors M5 and M6 and two KTP crystals. M5 was AR coated at 1064 nm and HR coated at
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the signal wavelength. M6 was AR coated at 1064 nm and had 40% partial transmittance at the
signal wavelength. Both of the mirrors were made of quartz to avoid absorption at the signal
laser.
Laser Diode

Lenses
M1
Fold
Mirror

Fold
Mirror
Coupling

Lenses

Signal
M8

Laser Diode

Figure 2.1: Schematic of 1.7 µm OPO Laser. M1, M2, M5, M6, flat mirrors; M3, M4, M8,
reflective mirrors; M7, dichroic mirror; KD*P, potassium dideuterium phosphate Pockels cell;
KTP, potassium titanyl phosphate. The inset shows the pictures of the actual laser system.
Here, the two KTP crystals with a size of 7×7×20 mm3 were cut in a special way (θ,
63.5°; Φ, 0°) to realize type II phase matching. It effectively reduced the walk-off effect by
placing two KTP crystals with adverse orientations, while the effective nonlinear coefficient was
still acceptable [73, 74]. In order to reduce loss, both sides of the KTP crystals were AR coated
at the pump, signal, and idler light. In the laser system, the length of the OPO cavity was
designed to be as short as 44 mm, since a short length leads to a low conversion threshold power
density. To dissipate heat effectively, the laser rods and KTP crystals were wrapped with indium
foil and tightly mounted in water-cooled heat sinks. The temperature of the cooling water was
kept at around 295 K. After the OPO, the pump beam was separated by the dichroic mirror M7
and blocked by a dump; while the signal beam was separated by M7 and then redirected to be the
final output by the reflective mirror M8. It is important to note that all these optical components
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for the OPO were installed in a compatible aluminum alloy box with a size of 36×27×10 cm3
shown by the inset pictures of Fig. 2.1. The compactness of the laser will make the entire IVPA
imaging system much easier for clinical translation in an operating room.
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Figure 2.2: Performance of the KTP-based OPO. (a) Repetition rate. (b) Laser emission spectrum.
(c) Output power at different current. (d) Pulse duration at different output power. (e) Pulse
duration at output power of 0.726 W. (f) Pulse-to-pulse variation.
We characterized the performance of the KTP-based OPO. Beam quality factor is less
than 1.3. The pulse repetition rate of the OPO is 500 Hz, as the time interval between every two
neighboring pulses is 2 ms in Fig. 2.2a. The output spectrum was measured by a NIR
spectrometer (LF-1250, Spectral Evolution, MA). The peak position in the spectrum is centered
at 1724 nm, which matches the first overtone vibrational band of C-H bond (Fig. 2.2b). The
output power increases with the control current with a maximum power of 1 W (2 mJ for pulse
energy) measured at 8.5 A (Fig. 2.2c). As shown in Fig. 2.2d, the pulse duration is slightly
increased with the output power ranging from 10.7 to 13.7 ns by measuring the FWHM of a
single laser pulse. The pulse width with the output power of 0.726 W is 13.2 ns, at which we
performed all of the experiments (Fig. 2.2e). Since PA imaging does not have a critical
requirement on the pulse width in this range, the OPO can be used for IVPA imaging with a
different power in this tunable range. The average pulse energy is characterized to be 1.452 mJ
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with 0.726 W output power. The pulse energy coupled to the catheter head was kept at 0.4 mJ.
Thus, the energy density at the surface of the catheter was calculated to be 0.1 J/cm2, which is
below the 1 J/cm2 ANSI safety standard for skin at this wavelength [75]. The pulse-to-pulse
variation is 6.27% (Fig. 2.2f), which ensures the same amount of photon delivery for each A-line
at different angles.
2.2.2

High-speed IVPA imaging system
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Figure 2.3: IVPA/IVUS imaging system. MMF, multimode fiber; L, lens.
The entire high-speed IVPA imaging system was constructed by integrating the KTP-based OPO
laser, the IVPA catheter, a scanning system, and data acquisition units (Fig. 2.3). The OPO
output was focused by a lens with a focal length of 75 mm into a 200 µm-core multimode fiber
(FG200LCC, Thorlabs, NJ) mounted on a 3D adjustable stage. After the 2 m long fiber, the beam
was then coupled into the IVPA catheter by two fixed-focus collimators mounted on the
scanning system. We designed a co-registered IVPA/IVUS dual-modality imaging catheter (inset
of Fig. 2.3). The IVPA catheter was composed of a miniaturized ring-shape ultrasound
transducer (center frequency, 35 MHz; band width, 65%; focal length, 3 mm), an end-polished
400 µm-core multimode fiber (BFL48-400, Thorlabs, NJ), a 45-degree rod mirror with a
diameter of 2 mm (Edmund Optics Inc., NJ), a homemade metallic housing and a 55 cm long
torque coil. For ultrasound transducer, single crystal Pb(Mg1/3Nb2/3)O3-PbTiO3 was adopted as
the function piezoelectric material, which provides superior electromechanical coupling
coefficient. The transducer/fiber and rod mirror were fixed in a metal housing with an open
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window for both light and sound delivery. Based on same design as used in the previous work
[68], both the excitation light and the ultrasound transmission were reflected 90 degrees by the
mirror, which maximized the optical-acoustic overlapping area and thus provided the largest
sensitivity. The trigger of the laser was used to synchronize the data acquisition for both IVPA
and IVUS imaging. A delay generator (37000-424, Datapulse Inc.) was used to set a 20 µs delay
between the laser pulse and the initial ultrasound (US) pulse (the voltage of the transmitted pulse,
180 V) generated by an ultrasound pulser/receiver (5073PR Olympus, Inc). Both the generated
PA and US signals were detected by the ring-shape transducer and then sent to the ultrasound
pulser/receiver with a total amplification of 39 dB. These signals were digitized and transferred
by a data acquisition card with 16 bits digitization and 180 MS/s sampling rate (ATS9462 PCI
express digitizer, AlazerTech, Canada) installed in a personal computer (PC). The data
acquisition software was developed to control, save, and process the recorded data in LabVIEW.
The data analysis was then performed off-line by Matlab. In the Matlab script, each A-line was
band-pass filtered (bandwidth: 9.5-50 MHz), Hilbert transformed for the signal envelop and
subtracted by an averaged background. The final polar image (cross-sectional image) was
constructed by 500 A-lines with a rotation speed of 1 frame per second. The dynamic range of
each polar image was log compressed and then normalized. None of the images in the
experiment was averaged. The rotation of the catheter was driven by a scanning system. We
designed the scanning system by integrating a homebuilt optical rotary joint and a linear stage
with an electrical slip ring (LPC-12T, JINPAT Electronics). The optical rotary joint delivered the
laser light through free-space coupling by the collimators (concentrically aligned with a bearing)
and rotated the catheter for the cross-sectional scanning. A linear stage was used for linear
pullback to ultimately acquire three-dimensional imaging. The electrical slip ring was used to
transmit the recorded signal from the transducer wire to the ultrasound pulser/receiver. Both the
optical rotary joint and the linear stage were controlled by the PC.
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2.3

Results

2.3.1

Performance of high-speed IVPA imaging system
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Figure 2.4: IVPA imaging of 30 µm carbon fiber phantom. (a) IVPA image with schematic of
carbon fiber phantom. Black dot indicates 30 µm carbon fiber. (b) IVUS image. (c) The axial and
lateral resolutions of IVPA imaging at axial position of 3 mm. (d) The spatial resolutions of
IVPA imaging as a function of the axial positions.
To characterize the spatial resolution of the high-speed IVPA imaging system, a carbon fiber
with a diameter of 30 µm carbon fiber was imaged. As shown in the inset of Fig. 2.4a, the carbon
fiber was placed at the depth of 3 mm in D2O environment. Both PA and US signals were
collected and reconstructed as IVPA (Fig. 2.4a) and IVUS (Fig. 2.4b) images through the highspeed IVPA imaging system. The dynamic ranges for displayed IVPA and IVUS images are 60
dB and 90 dB, respectively. The co-registration of IVPA and IVUS imaging was clearly reflected.
In Fig. 2.4c, according to the IVPA image, the experimental data of the imaged carbon fiber was
plotted along its axial and lateral directions, respectively. The dotted lines were then fitted with
Gaussian functions to estimate the axial and lateral resolutions of IVPA imaging. Based on the
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FWHMs of the fitted functions, the axial resolution is estimated to be 102 µm, while the lateral
resolution is 260 µm. The axial resolution of IVPA is quite close to that of IVUS, since it
primarily depends on the transducer bandwidth. In Fig. 2.4d, the spatial resolutions of IVPA
imaging were measured and plotted as a function the axial positions. Both axial and lateral
resolutions are maintained at the same levels, which shows the advantage of ring-shape
transducer-based IVPA catheter.
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Figure 2.5: IVPA imaging of lipid-mimicking phantom. (a) Schematic of phantom structure. (b)
IVPA image. (c) IVUS image. (d) Merged IVPA/IVUS image.
To characterize the sensitivity and specificity, we made a lipid-mimicking phantom with
butter for bond-selective IVPA imaging. The phantom structure is depicted in Fig. 2.5a. 2.5%
agarose-D2O gel acts as the tissue environment. One big hole, for IVPA catheter to be inserted in,
and three small holes, two filled with butter while one left blank, were reserved in the agarose
gel. The whole phantom and IVPA catheter were immersed in D2O medium for IVPA imaging to
avoid water absorption at 1.7 µm. Using the high-speed IVPA imaging system, the B-scan IVPA,
IVUS and merged IVPA/IVUS images of the phantom were obtained and shown in Fig. 2.5b,
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Fig. 2.5c and Fig. 2.5d, respectively. In the IVPA image with dynamic range of 39 dB, the two
holes with butter exhibit strong PA signal while the blank hole shows no evident signal. In the
IVUS image with dynamic range of 28 dB, all three holes provide contrast due to the boundaries
of the holes and the butter. The relative positions of the holes in the merged image further
confirm the co-registration of IVPA and IVUS imaging. The results above successfully
demonstrated the specificity for high-speed IVPA imaging and also the good sensitivity for lipid
detection.
2.3.2

Ex vivo high-speed IVPA imaging of human artery

To further validate the high-speed IVPA imaging system, an ex vivo study of an excised
atherosclerotic human femoral artery was performed. A small section of artery with
atherosclerotic plaque verified by a microscope was fixed in 2.5% agarose-H2O gel and
immersed in water for imaging purpose. The IVPA catheter was then inserted into the lumen of
the artery and rotated at a speed of 1 round per second. 500 A-lines were acquired during a cycle
to form a cross-sectional image. The IVPA (Fig. 2.6a), IVUS (Fig. 2.6b), and merged (Fig. 2.6c)
images of the atherosclerotic artery clearly show the complementary information of the artery
wall. Notably, the lipid deposition in the arterial wall indicated by white arrows at 2 and 3
o'clock directions, which is not seen in the IVUS image (dynamic range of 70 dB), shows high
contrast in the IVPA image with dynamic range of 54 dB. The lipid deposition in 2 and 3 o'clock
directions, although spatially stretched and distorted a little bit by the inserting catheter indicated
by some of the calcium lesion torn, was further confirmed by the gold standard histology of the
same cross-section of the artery (Fig. 2.6d). In the histology, the lipid shows up with red color
and areas of calcification are black when stained with Oil Red O. The lipid deposition in 7
o'clock direction was not successfully picked up by IVPA imaging. There are two possible
reasons, either caused by catheter induced spatial distortion or by the histology process, where
exact the same cross-section was not sliced. During the experiment, the energy density at the
catheter head was maintained at 0.1 J/cm2, which is below the ANSI safety standard for a
nanosecond laser at this wavelength. The imaging and histology results further confirmed the
capability of the high-speed IVPA imaging system for lipid detection accurately and specifically.
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Figure 2.6: High-speed IVPA/IVUS imaging of an excised atherosclerotic human femoral artery.
(a) IVPA image. (b) IVUS image. (c) Merged IVPA/IVUS image. (d) Cross-sectional view of
the artery histologically assessed for lipids with Oil-Red-O staining. The red indicates the lipid
deposition in the artery and the black indicates areas of calcification.
2.4

Conclusions and discussion

In this study, we have developed a compactible KTP-based OPO with an 2 mJ output at the
wavelength of 1724 nm and repetition rate of 500 Hz and demonstrated its use for high-speed
IVPA imaging of lipid deposition inside an intact human artery wall. The performance of the
IVPA imaging system’s resolution, sensitivity and specificity were successfully characterized by
a 30 µm carbon fiber and a lipid-mimicking phantom through a ring-shape transducer-based
IVPA catheter. The axial and lateral resolutions were measured to be 102 µm and 260 µm,
respectively. Although the catheter we used has a relative large diameter, the constant spatial
resolutions along the axial positions and the large optical-acoustic overlapping area make this
design advantageous when compared with front-back and dual-element transducer designs [71,
72]. For clinical applications, our catheter size should be further reduced to ~1 mm in diameter.
The size of our IVPA catheter is mainly determined by the size of ring-shape transducer. The
current size of ring-shape transducer (2.5 mm) is limited by the traditional fabrication method of
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mechanical turning and drilling due to the multi-layer structure of transducer as well as the small
stiffness of piezoelectric material. Currently, our group is working toward to reducing the
transducer size down to 1 mm in diameter by using the two available advanced micro-machining
techniques: laser cutting and inductively coupled plasma (ICP)-enhanced deep reactive ion
etching (DRIE). Nd: YAD solid-state laser cutting system is able to precisely drill and cut the
ceramic substrate of ultrasonic transducer with a narrow kerf less than 10 microns and up to 1
mm thickness. Moreover, the ICP-DRIE method commonly used for composite material
fabrication can also be easily adapted to fulfill the requirements of transducer minimization. The
improvement on spatial resolutions based on IVPA catheter designs also increases the detection
accuracy of lipid distribution, thus provides more accurate diagnosis of plaque vulnerability.
Another improvement to be addressed is the laser source with even higher repetition rate.
Currently, the IVPA imaging speed is primarily driven by the availability of high repetition rate
laser source with wavelengths that generate relative contrasts. In order to make IVPA imaging
competitive for clinical applications, the imaging speed has to be increased to ~30 frames/sec,
comparable with the typical imaging speed of clinical IVUS. The least number of A-lines
forming a cross-sectional IVPA image is determined by the lateral resolution. Based on our
imaging results and Nyquist sampling theorem, the least number of A-lines is
2π ×Viewing depth
= 125
Lateral resolution

with lateral resolution of ~250 µm and viewing depth of 5 mm. Thus, the

laser repetition rate needs to be at least 3750 Hz. If the number of A-lines is increased to be the
same with clinical IVUS (256 A-lines typically), then the repetition rate needs to be ~7500 Hz.
If the lateral resolution goes to the optical resolution, then the repetition rate needs to be much
higher. Therefore, we need further improve our laser with high repetition rate of the order of 10
kHz. It still is possible by using a KTP-based OPO to generate the high-energy pulsed laser with
~10 kHz repetition rate at 1.7 µm for clinical IVPA imaging and we are now working toward to
engineering such laser. Moreover, the compactness of the laser facilitates clinical translation of
the IVPA imaging system.
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3. HIGH-SENSITIVITY INTRAVASCULAR PHOTOACOUSTIC
IMAGING OF LIPID-LADEN PLAQUE WITH A COLLINEAR
CATHETER DESIGN

This work presented in this chapter was published in Scientific Reports [76] (reprinted with
permission from Nature Publication Group, copyright by 2016 Nature Publication Group).
Abstract: A highly sensitive catheter probe is critical to catheter-based intravascular
photoacoustic imaging. Here, we present a photoacoustic catheter probe design on the basis of
collinear alignment of the incident optical wave and the photoacoustically generated sound
wave within a miniature catheter housing for the first time. Such collinear catheter design
with an outer diameter of 1.6 mm provided highly efficient overlap between optical and
acoustic waves over an imaging depth of >6 mm in heavy water medium. Intravascular
photoacoustic imaging of lipid-laden atherosclerotic plaque and perivascular fat was
demonstrated, where a lab-built 500 Hz optical parametric oscillator outputting nanosecond
optical pulses at a wavelength of 1.7 µm was used for overtone excitation of C-H bonds. In
addition to intravascular imaging, the presented catheter design will benefit other
photoacoustic applications such as needle-based intramuscular imaging.

3.1

Introduction

Cardiovascular disease has been the leading cause of death in the United States and many
other developed countries over the past century [77]. Atherosclerosis, a major form of
cardiovascular disease, is caused by the chronic accumulation of lipids and fibrous elements
within the wall of an artery. This plaque can grow and become clinically symptomatic if it
significantly encroaches and obstructs the lumen of the artery. A plaque may also rupture and
result in acute coronary syndrome or even sudden death [3, 56]. Therefore, the early detection
of plaques that are vulnerable for rupture is essential in the diagnosis, treatment, and
prevention of cardiovascular diseases. Currently, there are no clinically reliable imaging tools
to accurately identify vulnerable atherosclerotic plaques, which are characterized post-mortem
by a large lipid core and thin fibrous cap [13]. Non-invasive modalities such as X-ray
angiography, magnetic resonance, and computed tomography angiography have been used to
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visualize obstructive stenosis in coronary arteries. However, vulnerable plaques prone to
rupture are often non-obstructive or moderately obstructive, thus evading detection by these
modalities [10]. Intravascular ultrasound (IVUS) can provide important morphologic
information of arteries including lumen geometry, plaque burden, and vessel structure.
However, the sensitivity and specificity for differentiation of plaque composition is limited,
partly due to the lack of chemical contrast with IVUS [78, 79]. Intravascular optical
coherence tomography [80, 81] has been reported, but these two optical imaging modalities
fail to provide necessary imaging depth and chemical specificity for vulnerable plaque
detection. Near infrared spectroscopy [60] provides chemical selectivity but it lacks the
spatial resolution to define the lipid core size and its detection sensitivity is compromised by
scattered photons.
Catheter-based intravascular photoacoustic (IVPA) imaging [82-85], on the basis of
converting the overtone vibrational absorption in an arterial tissue into thermoelastic waves
detectable with an ultrasonic transducer [36, 39, 86], is an emerging modality with potential
of bridging the aforementioned gaps. IVPA imaging offers the following advantages. First,
the optical absorption-induced contrast provides a unique approach to differentiate chemical
composition of arteries. Second, the imaging depth of IVPA is extended beyond the ballistic
regime owing to the diffused photon absorption and 2-3 orders of magnitude lower acoustic
scattering in tissues compared to optical scattering [87]. Third, by sharing the same detector,
IVUS is inherently compatible with IVPA imaging. Such a hybrid modality provides
complementary information of the tissue.
A clinically feasible IVPA catheter should be of small diameter, flexible, capable of
imaging through blood, and acquiring images with high sensitivity and chemical specificity at
an acceptable frame rate. These requirements collectively render the design and fabrication of
a high-performance IVPA probe to be one of the most challenging tasks in the photoacoustic
imaging field. A number of groups have reported IVPA catheters with diameter approaching
the clinical requirement of about 1 mm [52, 70-72, 82-85, 88, 89]. Specifically, the Emelianov
group reported two designs of IVPA catheters, one based on side fire fiber and the other based
on mirror reflection [82]. Both designs were based on a front-to-back arrangement of the light
delivery element and ultrasonic transducer. The Chen group introduced another design of
IVPA catheter based on parallel arrangement of side-firing fiber and transducer, where two
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different frequencies, 35 MHz and 80 MHz, of the transducer were performed to demonstrate
an outstanding axial resolution of 35 µm [89]. The Xing group introduced an intravascular
confocal photoacoustic probe with dual-element ultrasound transducer [72]. The Song group
reduced the diameter of IVPA catheter probe to 1.1 mm by carefully arranging the positions of
the optical and acoustic elements [88]. In their most recent work, the authors further reduced
the probe diameter to 0.9 mm [71]. Despite these advances, sufficient arterial imaging depth
has not been shown for these single-element transducer based IVPA catheters, largely because
the optical and ultrasonic waves were cross overlapped in a very limited space. Although the
overlap range can be altered by changing the coupling angle [90], it is hard to maintain the
photoacoustic sensitivity constant along the millimeter-scale imaging depth. Furthermore, the
IVUS and IVPA images in these non-collinear designs are not truly co-registered along the
imaging depth, which may lead to poor localization of artery and plaque features. Assembly
of the non-collinear design is also nontrivial, as all the components must be constrained to a
limited space. To maximize the overlap of incident optical field and generated acoustic wave,
our team recently demonstrated a coaxial design based on a ring-shaped transducer [68].
However, the outer diameter of the probe (2.9 mm) needed to be further reduced for clinical
compatibility.
Here, we report an IVPA catheter probe based on a collinear alignment of optical and
acoustic waves to overcome the drawbacks in aforementioned IVPA catheters. In our
approach, an optical beam delivered through a 365-µm-core multimode fiber (MMF) with a
low numerical aperture of 0.22 allowed quasi-uniform illumination along the imaging depth.
An outer diameter of 1.6 mm was reached for the catheter tip through careful arrangement of
the optical and acoustic elements. This collinear design ensured an efficient overlap between
optical and photoacoustic waves over 6 mm imaging depth. The capability of our collinear
design catheter probe was evaluated through ex vivo high-speed IVPA imaging of a diseased
porcine carotid artery and a human coronary artery, with optical excitation via a lab-built
optical parametric oscillator (OPO) outputting optical pulses at 1.7 µm wavelength and
500 Hz repetition rate.
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3.2

Methods and materials

3.2.1

Fabrication of a collinear catheter

The collinear IVPA catheter was fabricated according to the following procedures: (1) a
catheter housing with structure shown in Fig. 3.1 was 3D printed with micro-resolution
stereolithography process (Proto Labs, Inc.); (2) a custom-designed single-element transducer
with dimensions of 0.5 × 0.6 × 0.2 mm3, center frequency of 42 MHz and bandwidth of 60%
(Blatek, Inc.) was fitted in the square hole, with its sensing area facing the reflection plane; (3)
a section of MMF with core/cladding diameter of 365/400 µm, NA of 0.22 (FG365LEC,
Thorlabs, Inc.) was polished to 45° at one end and 90° at the other end with a fiber polisher
(NANOpol, ULTRA TEC Manufacturing, Inc.). The 45°-polished fiber end was then inserted
into the housing until matching with the acoustic reflection plane. The MMF was rotated
precisely to ensure the collinearity between the optical and acoustic waves; (4) a rod mirror
with diameter of 1 mm (Edmund Optics, Inc.) was inserted into the distal end of the catheter
housing, and tuned to ensure the optical beam illuminate radially; (5) the components were
glued, a torque coil was employed to enclose the optical fiber and electrical wire of the
transducer, and a fiber connector was installed on the distal end of the catheter. The relative
positions among each components are optimized by monitoring the photoacoustic signal in
real time under aqueous environment.
3.2.2 Scanning system and data acquisition
An optical rotary joint together with a slip ring were used to control the rotational scanning of
the catheter (Fig. 3.2). An additional pullback stage installed with the rotary joint was used to
enable 3-D imaging. The trigger signal provided by the Q-switch of OPO was used to
synchronize the data acquisition of IVPA and IVUS signals. A time delay of 10 µs was
applied to ultrasound pulser via a delay generator (37000-424, Datapulse, Inc.). Both IVPA
and IVUS signals are sequentially detected by the same transducer installed in the catheter
and received by a pulser/receiver (5073 PR, Olympus, Inc.) with an amplification factor of 39
dB. A data acquisition (DAQ) card (ATS9462 PCI express digitizer, AlazerTech, Canada)
with 16-bit digitization and 180 MS/s sampling rate was used to digitize and transfer the
generated signals via a LabView software.
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3.2.3

Phantom and artery sample preparation

Lipid-mimicking phantom preparation. The 2.5% agarose gel made from agar powder and
D2O approximately mimics the tissue environment. A butter rod with a diameter of ~1.5 mm
and a small piece of intramuscular fat were embedded in the agarose gel as imaging targets. A
central hole in the phantom was reserved for catheter insertion. The phantom was fully
submerged in D2O during imaging experiment to ensure a lower optical loss at 1.7 µm.
Carotid artery specimen. The atherosclerotic carotid artery was harvested from a
miniature Ossabaw swine, which was fed with high-fat/cholesterol/fructose diet, and then
fixed in 10% formalin. Before imaging experiment, a segment of artery with suspected plaque
was selected and cut as a region of interest with the aid of a microscope. The artery segment
was then held by agarose gel and submerged under D2O for imaging experiment.
Human coronary artery sample. The right coronary artery was harvested from an
explanted human heart at the time of transplant. We excised the vessel from the ostium to
6 cm distally, leaving approximately 5 mm of surrounding perivascular fat attached. The
ostium was cannulated with an 8 F introducer sheath and side branches were ligated to allow
for pressure perfusion. The artery was then pinned in a Sylgard® 184 Silicone Elastomer tray
and submerged in phosphate-buffered saline at room temperature and was perfused to mimic
physiologic pressure during imaging.

3.3

Results

3.3.1

Collinear IVPA catheter

The design of the collinear catheter probe is shown in Fig. 3.1. A section of MMF is used for
delivery of light to the probe. The distal end of the MMF is polished to 45° for ultrasonic
wave reflection, while the optical wave still propagates forward after the polished end when
the optical fiber is submerged in an aqueous environment. A single-element ultrasonic
transducer is placed parallel to the MMF, with its sensing area facing the polished fiber plane.
Therefore, the optical and ultrasonic paths are collinear after encountering the polished
surface (shown in Fig. 3.1c). A 45° rod mirror right after the delivery fiber is served to
redirect both the optical and ultrasonic waves perpendicularly for side-view illumination and
imaging. It should be noted that the ultrasound trace after the rod mirror is designed to be
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perpendicular to its receiving plane within the catheter housing to prevent direct ultrasound
wave venting from the transducer as shown in Fig. 3.1c, which may cause errant image
reconstruction. This design ensures that optical and acoustic waves are collinear within a large
tissue depth. The components involved are installed in a well-designed housing with an outer
diameter reasonably compatible in clinical settings, thus greatly simplifying the catheter
assembly process. A photograph of the lab-fabricated catheter probe is shown in Fig. 3.1d,
with its outer diameter measured to be 1.6 mm. The detailed procedure of the catheter
fabrication can be found in the Methods section.
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Figure 3.1: Collinear IVPA catheter probe. (a) Main components of the collinear catheter
before assembly. (b) Assembled IVPA catheter probe. (c) Zoom-in view of the catheter tip
with illustration of collinear overlap between optical and ultrasonic waves. (d) Photograph of
the fabricated catheter probe with a diameter of 1.6 mm, and the detailed structure of the
catheter tip (inset).

3.3.2

Architecture of IVPA imaging system

The schematic IVPA imaging system is shown in Fig. 3.2. A lab-built potassium titanyl
phosphate (KTP)-based OPO emitting at 1.7 µm with a repetition rate of 500 Hz and pulse
width of ~13 ns was used as the optical excitation source for photoacoustic imaging [55].
Light is coupled to the catheter via a MMF and an optical rotary joint. The pulse energy on
the catheter tip was controlled to be ~120 µJ, corresponding to an energy density of
~30 mJ/cm2 at the tissue surface, which is below the 1.0 J/cm2 ANSI safety standard for skin
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at 1.7 µm [75]. 3-D imaging of the system was enabled by a rotational scanning system and a
pullback stage. Sequential photoacoustic and ultrasound signals were generated and detected
with a proper time delay. The detailed information of the scanning system and data
acquisition can be found in Methods section. The current imaging speed of our system is 1
frame per second, which is 50 times faster than traditional IVPA imaging systems based on
10-Hz Nd:YAG lasers [82, 83, 85, 89]. The collinear catheter based imaging system was
subsequently characterized for performance evaluation and validated with ex vivo artery
imaging.
Optical rotary joint

Catheter

)

I Jt
Delay
generator

=

Probe

PC

Pulser/
Receiver
I
I
I
I
I

I
I

I
I

I
I

-----------J--------------------------------------------------·
Q-switch Trigger

Figure 3.2: Architecture of IVPA imaging system. OPO, optical parametric oscillator; DAQ,
data acquisition; PC, personal computer.

3.3.3

Characterization of spatial resolution and imaging depth

The spatial resolution of our catheter was evaluated by photoacoustically imaging a carbon
fiber with 7-µm diameter. The carbon fiber serves as a perfect target to determine the spatial
resolution of IVPA imaging due to its strong optical absorption and well-defined thin
diameter. The carbon fiber was positioned parallel to the catheter probe with a variable
distance controlled by a translation stage. The experiments were performed in deuterium
oxide (D2O) medium because of its lower optical absorption at 1.7 µm compared to water
[54]. Figure 3.3a shows the reconstructed cross-sectional photoacoustic image of carbon fiber
with a rotational catheter scanning. The inset shows the zoom-in view of the carbon fiber
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image. The generated photoacoustic signals along the axial and lateral directions centered at
the carbon fiber position are plotted in Fig. 3.3b,c to determine the spatial resolution. The
axial and lateral resolutions are derived from the full width at half maximum of Gaussian fit
of these results. An axial resolution of 81 µm and lateral resolution of 372 µm were obtained
at a radial distance of 2.2 mm. Spatial resolutions for photoacoustic imaging at different axial
distances were obtained similarly by changing the position of the carbon fiber as displayed
in Fig. 3.3d. The axial resolutions are found to fluctuate around 80 µm, which are primarily
determined by the bandwidth of the transducer, while lateral resolutions are found to varying
from 350 µm to 430 µm, which may be due to the non-focus property of ultrasonic transducer.
The magnitude of the photoacoustic signals at different axial distances is plotted as well
in Fig. 3.3e. It shows approximately an exponential decay along the axial direction. Notably,
the overlap range between optical beam and ultrasonic wave is found to be over 6 mm, which
has not been achieved for non-collinear catheter designs previously reported. This imaging
depth is sufficient for intravascular applications.
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Figure 3.3: Characterization of spatial resolutions and imaging depth. (a) Cross-sectional
photoacoustic image of a single 7-µm carbon fiber. (b) Axial resolution and (c) lateral
resolution obtained at an axial distance of 2.2 mm. (d) Axial and lateral resolutions at
different axial distances. (e) Magnitude of photoacoustic signal produced by the single carbon
fiber at different axial distances.

3.3.4

Chemical specificity validation with a lipid-mimicking phantom

A lipid-mimicking phantom composed of a butter rod and a portion of porcine intramuscular
fat were employed for photoacoustic imaging to evaluate the sensitivity and validate the
chemical specificity of our system. Similar to pathologic lipid deposition in atherosclerosis,
both butter and intramuscular fat are abundant in CH2 groups, which exhibit strong
absorptions at their first overtone transitions around 1.7 µm. Porcine intramuscular fat serves
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as a reliable model of pathologic lipid deposition, thus validating the feasibility of our
photoacoustic catheter probe to perform intravascular imaging. The procedure of phantom
preparation can be found in Methods section. Both photoacoustic and ultrasound images of
the phantom were shown in Fig. 3.4. We observed that both butter and fat can be identified
from both photoacoustic and ultrasound images, with strong association between them on
position and morphology. The signal-to-noise ratios for butter and fat in photoacoustic image
were calculated to be 38 and 18, respectively, while the signal-to-noise ratios are 30 and 46
for butter and fat in ultrasound mode. The photoacoustic signals are specific for the density of
CH2 bond in these two targets, while the ultrasound signals are related to the overall structural
properties. These results from the lipid-mimicking phantom validate the performance of
photoacoustic and ultrasonic imaging of lipid with our catheter, indicating our imaging system
can be used for reliable IVPA and IVUS imaging of an artery.

Figure 3.4: IVPA imaging of a lipid-mimicking phantom comprised of a butter rod and a piece of
porcine intramuscular fat. (a) IVPA image in green color map. (b) IVUS image in gray color
map. (c) Merged photoacoustic and ultrasound image. The 1 mm scale bar applies to all
panels. The shapes and positions of butter and fat are highlighted in yellow ellipses in panel
(a).

3.3.5

IVPA imaging of lipid-laden carotid artery excised from Ossabaw swine

The performance of our IVPA imaging system was validated by ex vivo imaging of a diseased
carotid artery (Fig. 3.5). A segment of the artery with suspected plaque (shown as artery
stenosis in Fig. 3.5d) was selected as the imaging target. Co-registered IVPA/IVUS images
were obtained as shown in Fig. 3.5a-c. From the IVUS image in Fig. 3.5b, the characteristic
three-layer appearance and luminal area of the carotid artery can be visualized, with the
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suspected plaque region and inner and outer boundaries of the artery inscribed, which agree
well with gross inspection at the plaque position (Fig. 3.5d). Strong photoacoustic signal
within the plaque region shown in Fig. 3.5a indicates a possible lipid-rich core of the plaque.
The co-registered image in Fig. 3.5c shows the overlap between the photoacoustic and
ultrasonic signal at the plaque area. The imaged cross-sectional region was further sectioned
and stained for histology, as shown in Fig. 3.5e. The lumen size and arterial structure were
verified by the histology. The plaque position was highlighted by a red box. The lipid
deposition, which might have been leached out during the histology process, is suggested by
the blank area. Some debris of the lipid core can still be visualized in the zoom-in view
indicated by black lines. The torn region of the artery in Fig. 3.5e is most likely an artifact
due to improper cryosectioning during histology.

Figure 3.5: Co-registered IVPA/IVUS imaging of a swine carotid artery ex vivo. (a) IVPA image.
(b) IVUS image. (c) Merged IVPA/IVUS image. (d) Gross photograph of the artery segment
with obstruction traced in the inset. Scale is shown by the ruler beside. (e) Histology of the
cross section of the artery at the IVPA imaging position. The lipid deposition is suggested by
the blank area highlighted in the box defined by yellow dashed lines. The 1 mm scale bar
applies to all panels except (d).
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3.3.6

IVPA imaging of fresh coronary artery excised from human patient

We further validated the capability of our collinear catheter design by ex vivo imaging a
perfused fresh right coronary artery from a human patient. The artery segment was imaged
with a 3-D scanning system composed by an optical rotary joint and a linear pullback stage.
At a particular longitudinal position, we identified a region of interest with strong
photoacoustic signal in the arterial wall, which could possibly indicate lipid depositions as
shown in Fig. 3.6. Furthermore, we observed intense photoacoustic signal peripheral from the
vessel wall with an imaging depth of 4.3 mm, suggested that our collinear IVPA imaging
system is able to penetrate through the entire arterial wall to reach the surrounding
perivascular fat that was retained on the excised vessel.

Figure 3.6: IVPA/IVUS imaging of a perfused fresh human right coronary artery dissected from
an explanted heart. (a) IVPA image. (b) IVUS image. (c) Merged IVPA/IVUS image. The
1 mm scale bar applies to all panels.
3.4

Conclusions and discussion

Compared to conventional non-collinear catheter designs, where optical and ultrasonic waves
only overlap partially within a limited range [72, 82, 83, 85, 88], the biggest advantage of our
collinear catheter design is that the generated ultrasonic wave shares the same path with the
optical excitation beam, which provides a highly efficient overlap between optics and
acoustics along the entire imaging depth. This development results in optimal photoacoustic
sensitivity over an imaging depth over 6 mm experimentally, allowing reliable access of the
deeper component information in the entire arterial wall, including perivascular fat. Even so,
the photoacoustic signal along an A-line still decays exponentially as shown in Fig. 3.3e. This
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decay can originate from a number of reasons including optical beam divergence, optical
absorption/scattering in imaging environment, the reduced collection angle of photoacoustic
wave at an increased depth due to its divergent property and the unfocused ultrasound
transducer, and acoustic loss in medium. Some approaches to reduce signal decay include
integrating a gradient-index lens in the catheter to improve the optical beam focusing,
introducing external wavefront shaping method to focus the light beam deeper inside the
tissue [91], and using a quasi-focused transducer to enhance the acoustic receiving efficiency.
The diameter of our current fabricated catheter probe is 1.6 mm, mainly limited by the
size of the rod mirror (1 mm diameter). With a reduced diameter of 0.5 mm for the rod mirror,
the catheter probe can be further reduced to ~1 mm in diameter, which is similar to the size of
commercially available IVUS catheter probes [92].
The imaging speed of our current system is 1 frame per second, which is based on the
500 Hz repetition rate OPO and one revolution per second rotation speed of the catheter.
Considering the lateral resolution of ~425 µm at an axial distance of 5 mm, the number of Alines for each cross-sectional image can be reduced to 75, which would allow a maximum
imaging speed over 6 frames per second. We also intend to develop a similar laser system at a
higher repetition rate of 2 kHz, which will further improve our imaging speed to approach that
of commercial in vivo intravascular imaging systems [92].
In conclusion, we demonstrated a miniature IVPA catheter probe with collinear
overlap between the optical and acoustic fields. This design enabled high-quality IVPA
imaging of the entire artery wall from lumen to perivascular fat. The lab-fabricated collinear
catheter was evaluated for spatial resolution characterization with a 7-µm carbon fiber and
chemical composition validation by using a lipid-mimicking phantom. The axial and lateral
resolutions were found to be around 80 µm and 400 µm, respectively, over an imaging depth
larger than 6 mm. With a co-registered IVPA/IVUS imaging system based on a lab-built
500 Hz OPO at 1.7 µm, the catheter was used to image a diseased carotid artery and a human
coronary artery ex vivo, resulting in IVPA/IVUS images showing a lipid-rich plaque that
corresponds with gross inspection. These results collectively help the photoacoustic imaging
community to move towards the realization of in vivo IVPA imaging in the clinic.
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4. REAL-TIME INTRAVASCULAR PHOTOACOUSTIC-ULTRASOUND
IMAGING OF LIPID-LADEN PLAQUE IN HUMAN CORONARY
ARTERY AT 16 FRAMES PER SECOND

This work presented in this chapter was published in Scientific Reports [93] (reprinted with
permission from Nature Publication Group, copyright by 2017 Nature Publication Group).
Abstract: Intravascular photoacoustic-ultrasound (IVPA-US) imaging is an emerging hybrid
modality for the detection of lipid-laden plaques, as it provides simultaneous morphological and
lipid-specific chemical information of an artery wall. Real-time imaging and display at videorate speed are critical for clinical utility of the IVPA-US imaging technology. Here, we
demonstrate a portable IVPA-US system capable of imaging at up to 25 frames per second in
real-time display mode. This unprecedented imaging speed was achieved by concurrent
innovations in excitation laser source, rotary joint assembly, 1 mm IVPA-US catheter size,
differentiated A-line strategy, and real-time image processing and display algorithms. Spatial
resolution, chemical specificity, and capability for imaging highly dynamic object were
evaluated by phantoms to characterize system performance. An imaging speed of 16 frames per
second was determined to be adequate to suppress motion artifacts from cardiac pulsation for in
vivo applications. The translational capability of this system for the detection of lipid-laden
plaques was validated by ex vivo imaging of an atherosclerotic human coronary artery at 16
frames per second, which showed strong correlation to gold-standard histopathology. Thus, this
high-speed IVPA-US imaging system presents significant advances in the translational
intravascular and other endoscopic applications.

4.J

Introduction

Coronary artery disease remains the leading cause of morbidity and mortality throughout the
world. Atherosclerosis, a major form of coronary artery disease, occurs in many different forms
and can be distinguished by morphologic classification into different plaque types [6]. Among
them, the thin-capped fibroatheroma has been understood to be the most “vulnerable” plaque
type, as evidence shows it is the most prone to rupture and progress to thrombosis and acute
coronary syndrome [6-8, 94]. Thin-capped fibroatheromas are grossly defined by hallmarks of a
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large lipid-rich necrotic core, a thin fibrous cap, and inflammatory infiltrate [7, 8]. In addition,
these plaques are often structurally non-obstructive to moderately obstructive, thus clinically
unidentifiable by routine angiography and stress testing [7, 11, 12]. Currently, there are no
clinically available imaging tools to reliably and accurately detect vulnerable plaques [13-15].
Angiographic techniques, including X-ray angiography, computed tomography angiography, and
magnetic resonance angiography, are limited to visualizing areas of severe luminal narrowing.
Intravascular ultrasound (IVUS) provides the overall morphology of artery wall for
quantification of the plaque burden and monitoring disease progression, but lacks chemical
selectivity to identify plaque composition. Virtual-histology IVUS, based on radiofrequency (RF)
analysis of the ultrasound signal, provides valuable information of the plaque composition [16,
95], but still has not been thoroughly validated [18, 96]. Intravascular near-infrared spectroscopy
(NIRS) has been shown to reliably detect lipid-rich plaques in the artery wall [21, 22], but lacks
imperative depth resolution to quantify the size and location of the lipid deposition. Intravascular
optical coherence tomography can accurately detect fibrous cap thickness with micron-scale
resolution [20], but lacks sufficient imaging depth and chemical selectivity to wholly determine
plaque composition. These gaps, along with the increasing prevalence of coronary artery disease,
highlight an unmet clinical need for a chemically-selective imaging modality with spatial
resolution to advance the detection, understanding, and treatment of lipid-laden vulnerable
plaques.
Dual-mode intravascular photoacoustic-ultrasound (IVPA-US) imaging is a promising
approach to bridge the aforementioned gaps. In this hybrid modality, IVPA channel maps the
lipid-specific chemical composition over the entire artery wall with ultrasonic spatial resolution.
Based on conversion of optical absorption into ultrasound signal, photoacoustic (PA) imaging
provides chemical selectivity and deep penetration depth [25, 33, 86, 87]. Specifically, the lipidspecific contrast is generated endogenously from the first overtone absorption of C-H bonds at
1.7 µm wavelength [36, 39] and the PA signal is one order of magnitude greater than that of
water and connective tissues [36]. Furthermore, IVPA imaging works concurrently with IVUS
imaging, which can provide simultaneous morphological information. Therefore, a co-registered
IVPA-US image provides complementary information necessary for advanced and quantitative
assessment of lipid-laden vulnerable plaques.
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The IVPA-US imaging technology is currently under active investigation for the
identification of various tissue components [39, 51, 53], contrast mechanism [36, 39], optical
excitation sources [68, 71, 97], IVPA-US catheter designs [71, 72, 76, 82, 88], and ex vivo and
preclinical validations [69, 70, 83]. However, these works are limited by the use of slow imaging
speeds (up to 5 frames per second (fps) [71]) as well as lack of real-time image display, which
are necessary components for future in vivo applications where imaging must be at a sufficient
speed to avoid motion artifacts from cardiac pulsation. Motion artifacts can lead to inaccurate
spatial mapping and quantification of lipid deposition, and subsequent misinterpretation of
plaque type. Furthermore, a lack of real-time processing and display capability would prevent
user feedback necessary to adjust imaging parameters and location.
In this work, we overcame these limitations by presenting a portable IVPA-US system
capable of imaging in real-time, up to 25 fps. In this system, a master oscillator power amplifier
(MOPA)-pumped optical parametric oscillator (OPO) with a wavelength of 1.7 µm and a
repetition rate of 2 kHz was used as the optical excitation source. A compact fiber-optic rotary
joint provided efficient and stable optical coupling with a scanning speed up to 30 revolutions
per second. A 1 mm diameter collinear IVPA-US catheter was built for high-sensitivity imaging.
A differentiated A-line strategy, where the triggering frequency for US was doubled to that of
PA, was applied to maximize IVPA-US imaging functionality. Lastly, LabView-based
algorithms were developed to process and display IVPA-US images in real-time. These
developments enabled the 25 fps imaging speed, a 5 times improvement over any previously
reported IVPA-US imaging speed and comparable to the imaging speeds of current commercial
IVUS and NRIS-IVUS systems [98].

4.2

Methods and materials

4.2.1

MOPA-pumped OPO

The detailed optical layout of the laser was shown in Fig. 4.1a. In the MOPA configuration, a
Nd:YAG laser side-pumped by a laser diode was used as the master oscillator, generating 2.5 mJ
and 15 ns laser pulses at a frequency of 2 kHz and a wavelength of 1064 nm. The output of the
laser diode was collimated onto the Nd:YAG crystal through a pair of coupling lenses. A BBO
Pockels cell was used as the electro-optical Q-switch along with a polarizer and a quarter-wave
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plate. A Nd:YAG rod side-pumped by a collimated laser diode was applied as the power
amplifier. After the amplification, the pulse energy reached 6.0 mJ at a wavelength of 1064 nm
and a pulse duration of 15 ns. The wavelength of the laser pulses was shifted to 1.7 µm as the
final output by a KTP-based OPO. In the OPO cavity, two KTP crystals were specially cut to
realize the type II phase matching and placed with opposite orientation to effectively reduce the
walk-off effect. The temperature of the laser rods and the KTP crystals were kept at 295 K for
effective heat dissipation. All optical components were installed and enclosed in a compatible
aluminum alloy box with dimensions of 107×260×430 mm3. The performance of the laser
output was further characterized as shown in Fig. 4.1b,c and Fig. 4.2.
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Figure 4.1: 1.7 µm 2 kHz MOPA-pumped OPO for high-speed optical excitation. (a) Schematic
of MOPA-pumped OPO. Dashed boxes labeled by I, II, and III highlight the master oscillator,
optical power amplifier, and OPO, respectively. LD, laser diode; CL, coupling lens; M1 and M5,
fold mirror; M2, M10, and M11, flat mirror; M3, M4, M6, M7, M8, M12, and M13, reflective
mirror; M9, dichroic mirror; P, polarizer; BBO, beta barium borate Pockels cell; OC, output
coupler; L, lens; KTP, potassium titanyl phosphate; W, output window. (b) Output wavelength of
the laser (black curve), 1725 nm, matching the maximum peak in photoacoustic spectrum of
lipids (blue curve). (c) Output power with control current.

40

b

C

2.5

1.4
1.0

[

2.0

.,...

~
0
C.

1.5

:i

1.0

.e-::,

0

.,.,.-•-········•··

~0.8

./
./
./

0.0

_.,/

I

~
-~ 0.6

•'•'

:s.,

./

0.5

1.2

i

✓

.,e,

0.4

.,5i

0.6

'0

~ 0.2

!!!.
::,

0.4

"'

IL

L.o

0.2

z
0.0

0.2

0.4

0.6

0.8

1.0

-40

-20

0

Power percentage

d

1.0
0.8

20

40

0.0

60

0

20

40

60

80

100

Pulse number

Time (ns)

f

e
2.0
160

200
1.5

~ 140

[

.,

.,

-150

~ 1.0

'0

;;

~
0

'0

;2

i
.;

120

t

IL

'ii

100

<

0.5

E

<

100

50
2

3

Time (ms)

0.0

0

2

4

Position (mm)

50

100

150

200

250

300

Time (ns)

Figure 4.2: Performance of 1.7 µm 2 kHz MOPA-pumped OPO. (a) Output power with power
percentage. This was a second way to control the laser output power in the range of 0-2.1 W (0
to 1.05 mJ for pulse energy) by changing the power percentage. The percentage refers to the
output power to its maximum power, with the output power controlled by the pump delay of 144
to 27 µs. (b) Pulse width of 11.46 ns±0.68 ns was measured by the FWHM of single pulse
profile measured with an output of 1.5 W. (c) Pulse-to-pulse energy variation was 5.6%,
indicating that pulse energy normalization for each A-line was not necessary. (d) Laser pulse
repetition rate, 2 kHz, measured by a fast photodiode. (e) Output beam waist measurement by
knife-edge method. The waist was 1.75 mm, a parameter used in laser fiber-optic coupling. (f)
Delay between laser pulse and output TTL trigger was 126.40±0.42 ns, which can be regarded
as constant and used for precise event triggering and synchronization.

4.2.2

IVPA-US catheter

We designed and assembled a new 1 mm catheter for simultaneous IVPA and IVUS imaging.
The detailed design was shown in Fig. 4.3a,b. In the catheter, a multimode fiber (FG365LEC,
Thorlabs) was used to guide the optical beam. The proximal end of the fiber was polished to 90°
and assembled with a FC/PC connector for light coupling. The distal end was polished to 47° to
realize the collinear overlap between the optical and acoustic paths (Fig. 4.4), considering the
small difference in refraction index between the fiber core (1.44) and water or heavy water (1.33).
A single element ultrasound transducer (center frequency, 40 MHz; bandwidth, 52%; size,
0.5×0.6×0.2 mm3; Blatek Inc.) was used to receive generated PA and US signals sequentially. A
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45° rod mirror (made from the same fiber, polished to 45° and coated with gold, with an optical
reflection of 99% and a damage threshold of 1 J/cm2) was used to reflect both optical and
acoustic waves. The catheter housing (Proto Labs Inc.) was 3-D printed with micro-resolution
stereolithography process to enclose and align the relative positions of fiber distal end, rod
mirror, and ultrasound transducer. The fabrication was completed on a workstation capable of
aligning these components precisely and monitoring the PA and US signals in real-time under
aqueous environment.
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IVPA/US catheter tip
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Multi mode fiber
The proximal of
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Figure 4.3: 1-mm high-sensitivity catheter and fiber-optic rotary joint assembly for high-speed
IVPA-US imaging. (a) Gross picture of flexible IVPA-US catheter with a 1 cent coin. Proximal
end of the catheter was assembled with a FC/PC connector. (b) Schematic of 1-mm collinear
IVPA-US catheter design. The red ellipses and black curves highlight the collinear paths of
optical pulses and acoustic waves, respectively. Inset shows the actual picture of assembled
catheter tip. Ruler scale: 1 mm. (c) Picture of overall fiber-optics rotary joint assembly. (d)
Schematic of fiber-optic rotary joint for high-pulse-energy high-repetition-rate laser delivery.
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Figure 4.4: Laser beam characteristics at catheter tip. (a) Schematic of optical and acoustic paths
in catheter tip with top view. Red line, optical path; green line, acoustic path. In this design, the
optical path in the catheter tip was refracted by the silica-water interface, while the acoustic path
was reflected by the same interface. Both paths were collinearly overlapped after the interface
when the fiber-polishing angle, θ, was 47°. The angle was calculated by equation nd sin (90 −
θ) = nH sin(θ), where nd is 1.44, refraction index of pure silica in fiber core and nH is 1.33,
refraction index of water or heavy water. The deviation angle of optical path caused by refraction
was 4°, a very small angle. As the distance between the center point of the interface to the center
point of rod mirror, D, was ~500 µm, the distance between the optical reflection spot to the
center point of the rod mirror, d, was calculated as d ≈ Dsin (4°) = 35 µm. This distance was
small relative to the area of reflection surface of the rod mirror, so the laser pulse was effectively
reflected by the rod mirror. The 45° rod mirror was used to reflect the laser pulse to samples and
excite samples nearly perpendicularly at catheter output window. (b) Laser output profile at
catheter tip characterized by knife-edge measurement. The blue dots indicated the output power
measured along different positions of knife edge. The derivative of raw data showed that the
output beam had a Gaussian or Gaussian-like profile. The beam waist (ω =0.353 mm) was
estimated by Gaussian fitting the derivative points. The laser fluence, ϕ, was calculated by
equation ϕ = E/(πωH /2), where E is the pulse energy.

4.2.3 Data acquisition, image processing and display algorithm
In order to process and display IVPA-US images in real-time, we developed LabView-based
algorithms and an intuitive graphical user-friendly interface. First, we used a differentiated Aline strategy for IVPA and IVUS imaging by doubling the US triggering frequency. Specifically,
the TTL signal from the laser was used to trigger data acquisition. The same signal was also used
to generate two delayed TTL signals (one channel was delayed for 8 µs and the other for 258 µs)
through a delay generator (9512+, Quantum Composer). The two channels were further
multiplexed for triggering ultrasound pulser/receiver. Thus, the signal recorded in each
acquisition cycle contained one PA signal segment, two US signal segments, and the remaining
non-meaningful signal. The signal was then processed by developed image processing and
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display algorithms (the processing flow shown in Fig. 4.5). Finally, the IVPA and IVUS images
were displayed separately on screen in real-time. Using the same methodology as that in 16 fps
imaging, we achieved 10, 20, and 25 fps real-time image processing and display. In 10 fps
IVPA-US imaging, 200 and 400 raw A-lines were used to reconstruct cross-sectional IVPA and
IVUS images, respectively. Similarly, for 20 fps, 100 and 200 raw A-lines for IVPA and IVUS
images; for 25 fps, 80 and 160 raw A-lines for IVPA and IVUS images. For 1 and 5 fps, the US
triggering frequency was the same as PA, thus IVPA and IVUS images had the same number of
A-lines. For 1 fps, IVPA and IVUS images both had 2000 raw A-lines. For 5 fps, both images
had 400 raw A-lines. For off-line image reconstruction, an additional median filter was used to
reduce noise in both IVPA and IVUS images. An A-line interpolation method was further
implemented into the reconstruction algorithm smoothing both IVPA and IVUS images. This
was a method that applied interpolation for raw data points along the lateral direction, through
which the discontinuity between raw A-lines can be smoothed.
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Figure 4.5: Real-time IVPA-US image processing and display. The signal recorded in each cycle
contained one PA signal segment, two US signal segments, and the remaining non-meaningful
signal. The DAQ card recorded and digitized the signal in each cycle. The remaining signal was
discarded in a preprocessing loop and the PA and US signal segments were streamed separately
into parallel IVPA and IVUS loops. Both IVPA and IVUS loops processed the signal segment
sequentially through the following functions: digital bandpass filter (2 to 50 MHz bandpass);
Hilbert transform for signal envelop; polar projection to convert the series of A-line necessary
for a cross-sectional image into a polar image. The polar projection module generated a look-up
table, through which Cartesian coordinates were converted into polar coordinates for IVPA and
IVUS images simultaneously. This module was initialized before each data acquisition and
display, which means that the look-up table was only calculated once before recording and
displaying the data.
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4.2.4

IVPA-US imaging system

The portable IVPA-US imaging system was shown in Fig. 4.6. In the system, the laser output
was coupled to a multimode fiber (FG365LEC, Thorlabs). A designed fiber-optic rotary joint
(Fig. 4.3c,d) delivered the laser beam to the IVPA-US catheter tip sequentially through the
following optical parts: SMA collimator (F220SMA-C, Thorlabs) for beam collimation, a second
SMA collimator (F220SMA-C, Thorlabs) used for coupling the beam into a terminated fiber end,
a SMA-to-SMA mating sleeve (ADASMA, Thorlabs) used to properly align the cores of the
each terminated fiber end and minimize back reflection. Each terminated fiber end was
assembled with a SMA connector. The second collimator, the short fiber segment, and the
mating sleeve were fixed in place and enclosed by a metal rotor. Three bearings were assembled
onto the proximal end of the rotor and then installed into a stator; while the first collimator was
fixed in place into the other end of the stator. The rotator drove the rotor and the optical
components in the rotor at a set speed. A step motor (X-NMS17C-E01, Zaber) was used to drive
the rotator through a belt for cross-sectional scanning; a linear stage (X-LRM100A, Zaber) was
integrated for pullback. The speeds of rotational scanning and linear pullback were controlled by
a computer. The optical pulses and initial ultrasound pulses were sequentially sent to the IVPAUS catheter through the multimode fiber and the electric wire of the ultrasound transducer,
respectively, to generate IVPA and IVUS signals. The detected signal was transmitted through a
slip ring. Electronic noise induced by the assembly was suppressed by electrical grounding and
shielding. The signal was received and amplified (39 dB) by an ultrasound receiver (5073PR,
Olympus, Inc.), digitized and acquired by a DAQ card (ATS9350 PCI express digitizer,
AlazarTech) with waveform digitization of 12-bit, sampling rate of 500 MS/s, and data
throughput of 1600 MB/s. The digitized data was processed and displayed in real-time by the
computer. The laser chiller used was a non-compressor based chiller. This robust, compact, and
portable design is essential for future work in catheterization labs for preclinical and clinical
studies.
4.2.5

Human artery samples and histopathology

Human specimens were obtained within 24 hours of death from deceased patients bequeathed to
Indiana University School of Medicine, as approved by Institutional Review Board exemption.
The studied donor sample was from a 44-year old Caucasian male with a body mass index of
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32.4, past medical history of a previous myocardial infarction, smoking and alcohol use, and
hypertension, and died from atherosclerotic hypertensive cardiovascular disease. The right
coronary artery was excised from surrounding bulk myocardium. Small side branches were
ligated with ligation clips to allow for pressure-perfusion and the proximal portion of the artery
was cannulated using a modified 6F hemostatic introducer sheath. To maintain the vessel
morphology, we pressure-fixed the artery using 10% w/v formalin with a large barrel syringe
(140 mL Monoject, Covidien) for 20 minutes at 225 mL/min, which approximately translated to
a physiologic pressure. The artery was left in formalin overnight to ensure fixation. We imaged
the vessel by first submerging and perfusing it with room temperature 1X PBS, pH 7.4 to remove
all air. Next, we inserted the IVPA/US catheter, partially enclosed with a polyimide sheath,
through the hemostatic introducer sheath and advanced it distally to a point of resistance (from
tortuous anatomy). We completed a pullback of the entire artery length at a pullback rate of 0.2
mm/s and 1 fps imaging speed. After we identified a positive region of interest (an area with
strong signal from the IVPA channel), we repeated imaging at 16 fps. We identified and marked
the catheter tip location in the vessel at our imaged region of interest by using a metal pin that
was strongly echogenic on IVUS. This region was grossly segmented into a ~2.5 mm section and
further sectioned at multiple 250 µm levels and stained with Russell-Movat’s pentachrome.

4.3

Results

4.3.1 High-speed real-time IVPA-US imaging system
We designed and developed the compact and portable IVPA-US imaging system as shown in Fig.
4.6a. The detailed connections and controls of these components were shown in Fig. 4.6b.
Briefly, in the system, a 1.7 µm, 2 kHz MOPA-pumped OPO was used for high-speed optical
excitation. Its output pulses were coupled to a multimode fiber through a coupling mount, then a
fiber-optic rotary joint, and lastly the IVPA-US catheter tip. Initial ultrasound pulses generated
from an ultrasound pulser were sent to the catheter tip through a slip ring. The delays between
the ultrasound and optical pulses were precisely controlled by a delay generator. The B-scan and
linear pullback of the catheter was conducted with the fiber-optic rotary joint assembly and
rotation and pullback rate controlled by a computer. The sequentially generated PA and US
signals were detected by the IVPA-US catheter, transmitted by the slip ring, amplified by the
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ultrasound receiver, digitized and recorded by a data acquisition (DAQ) card, and further
processed and displayed in real-time. This IVPA-US system was capable of imaging in real-time
at speed up to 25 fps. The imaging speed was achieved by innovations in several key
components, which are presented as below.
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Figure 4.6: High-speed real-time IVPA-US imaging system. (a) Image of the portable IVPA-US
imaging system. Major components: 1, oscilloscope; 2, fiber-optic rotary joint assembly; 3,
IVPA-US catheter; 4, delay generator; 5, ultrasound pulser/receiver; 6, MOPA-pumped OPO; 7,
laser controller; 8, mobile cart; 9, laser chiller; 10, PC and DAQ card; 11, image display monitor.
(b) Schematic of IVPA-US imaging system layout. Dashed black line: trigger signal; solid black
line: stage control cable; solid green line: radiofrequency signal.
The determining factor for imaging speed is the laser pulse repetition rate, as each laser
pulse corresponds to a depth-resolved A-line signal. In this system, a custom-built MOPApumped OPO was used for 2 kHz optical excitation, with the optical layout detailed in Fig. 4.1a.
The master oscillator provided 2.5 mJ and 15 ns laser pulses at 1064 nm with a 2 kHz repetition
rate. The output was amplified to 6.0 mJ by a laser diode side-pumped optical power amplifier.
Its wavelength was further shifted to 1.7 µm by a potassium titanyl phosphate (KTP)-based OPO.
The performance of the laser output was further characterized. The final output wavelength was
measured to be 1725 nm, which coincides with the first overtone transition frequency of C-H
bonds (Fig. 4.1b). Thus, laser pulses at this wavelength were effectively absorbed by C-H bondrich lipids, which generated strong PA signals. The output power was tunable in a range of 2.1 W,
sufficient for lipid excitation (Fig. 4.1c). Other laser performance characterizations were shown
in Fig. 4.2. Collectively, this laser source was optimal for high-speed IVPA imaging of lipids.
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The catheter used in the system had a collinear IVPA-US design with a diameter of 1 mm.
Fig. 4.3a showed the actual image of a fully assembled collinear IVPA-US catheter, with the
detailed schematic of the catheter imaging window shown in Fig. 4.3b. In this design (further
details found elsewhere [76]), the incident optical wave and its generated ultrasound wave were
collinearly aligned, providing efficient overlap between the optical and acoustic paths over an
imaging depth of >6 mm. In this work, we further miniaturized the catheter diameter to 1 mm, a
clinically-compatible size adopted by most commercial IVUS systems. The reduction in diameter
was achieved by aligning a miniaturized single element transducer (0.5 × 0.6 × 0.2 mm3), a
multimode fiber with core diameter of 365 µm, and a reflection rod mirror with diameter of 365
µm in a 3-D printed housing. The beam path and beam characteristics were shown in Fig. 4.4.
The inset in Fig. 4.3b showed the actual image of an assembled IVPA-US catheter tip. This
catheter provided high-sensitivity IVPA-US imaging capability and its size made access into
human coronary artery samples feasible.
The fiber-optic rotary joint assembly is another key element that enabled the high-speed
imaging. The assembly simultaneously provided optical coupling, RF signal transmission, fast
rotary scan, and linear pullback. The compact and portable assembly was shown in Fig. 4.3c.
The rotary motor and the linear stage were used to provide rotary scan and linear pullback of
catheter for 3-D imaging. The fiber-optic rotary joint was used to provide sufficient and stable
optical coupling at high rotational speeds. The design of fiber-optic rotary joint was shown in Fig.
4.3d. In this design, the use of two adjacent collimators and a mating sleeve enabled an overall
coupling efficiency of 60% from the initial optical input to the final output at the catheter tip.
Furthermore, the design significantly minimized the coupling efficiency variation usually caused
by the mechanical rotation to 5.4%. Thus, the artery wall was uniformly excited in laser pulse
energy at every angular position. The fiber-optic rotary joint was further driven by the motor
with rotational speed up to 30 revolutions per second.
To maximize IVPA-US imaging functionality at high imaging speeds, a differentiated Aline strategy was designed. Fig. 4.7a showed the timing diagram for the A-line strategy. The
transistor-transistor logic (TTL) signal from the laser was used to trigger DAQ card. The same
trigger was delayed and frequency-doubled through multiplexing by a delay generator to trigger
initial ultrasound pulses. As a result, the digitized signal in one acquisition cycle contained one
PA signal segment and two US signal segments. Thus, the number of A-lines in a cross-sectional
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IVUS image was two times of that in IVPA image. Specifically, at 16 fps, 125 A-lines were used
to reconstruct a cross-sectional IVPA image; 250 A-lines were used to reconstruct a crosssectional IVUS image, comparable to current commercial systems. In order to verify the use of
125 A-lines in IVPA image, we characterized IVPA lateral resolution by imaging of a single 30
µm diameter carbon fiber submerged in heavy water. The cross-sectional IVPA image at 16 fps
was shown in Fig. 4.7b and its lateral resolution of 305 µm was estimated by the full-width-athalf-maximum (FWHM) of the Gaussian fitted curve of the raw data points in the lateral
direction at an axial position of 2.38 mm (Fig. 4.7c). At this axial position, there were 2.5 Alines sampled in the lateral resolution of 305 µm, which indicates that signals in IVPA image
were adequately sampled in the lateral direction based on the Nyquist sampling theorem (2.5 was
calculated by L/(2*pi*R/N), where L is the lateral resolution, N is the number of A-lines per
cross-sectional image, and R is the axial position). Using the same methodology, there were
constantly ~2.5 A-lines sampled in the lateral resolution at every axial position for 16 fps IVPA
imaging (calculated based on the data in Fig. 4.7d). Thus, the use of 125 A-lines should provide
adequate image quality for IVPA imaging. Meanwhile, we characterized the lateral resolutions at
different axial positions at other imaging speeds (Fig. 4.7d). Notably, when the axial position
was increased, the lateral resolution decreased, varying from 150 to 600 µm. However, there was
no significant difference in lateral resolution at each axial position at different imaging speeds.
To achieve real-time display of IVPA-US images, we developed fast processing and
display algorithms. The processing flow was shown in Fig. 4.5 and the details were in Methods.
Briefly, the digitized data containing non-meaningful signals was discarded in a preprocessing
loop. The remaining PA and US segments were processed, reconstructed, and displayed in
parallel IVPA and IVUS loops. A polar projection module was applied to convert IVPA and
IVUS signals into polar images simultaneously. Through this program, we were able to image
and display in real-time. (More details about the high-speed real-time IVPA-US imaging system
can be found in Methods).
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Figure 4.7: Differentiated A-line strategy and A-line number verification for IVPA-US imaging
at 16 fps. (a) timing diagram of IVPA-US imaging. �? , 0 µs; �d , 0.126 µs; �H , 8.126 µs; �e ,
258.126 µs. TTL trigger refers to the trigger signal from laser. (b) Cross-sectional IVPA image
of a single carbon fiber with diameter of 30 µm for spatial resolution characterization. The image
shown was reconstructed by raw imaging data without A-line interpolation. Inset shows the
zoom-in IVPA image. Scale bar: 1 mm. (c) Lateral plot of the carbon fiber in IVPA image at an
axial position of 2.38 mm. The lateral resolution of 305 µm is estimated by the full with at half
maximum (FWHM) of Gaussian fitted curve. (d) IVPA lateral resolution at different axial
position at imaging speeds of 1, 5, 10, and 16 fps.

4.3.2

IVPA-US imaging of pulsatile motion at different speeds

To find the optimal speed to image arteries with cardiac motion in in vivo settings, a phantom
with pulsatile motion mimicking a human heartbeat was imaged at different speeds: 1, 5, 10, 16,
20, and 25 fps. Heat shrink tubes have a high absorption and can generate strong PA signal in a
broad optical spectrum including 1.7 µm. Thus, we used a short heat shrink tube segment with a
~6 mm diameter in a heavy water environment as the phantom. At the time of imaging, the
pulsatile motion was generated by mechanically pinching the tube at 1.2 Hz with forceps. The
demonstration of real-time IVPA-US imaging of heat shrink tube at 16 fps and 25 fps can be
found in Supplementary Video S1 and Supplementary Video S2 of [93], respectively.
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Supplementary Video S3 of [93] showed the merged IVPA-US images at speeds of 1, 5, 10, 16,
20, and 25 fps, respectively. In this video, IVPA and IVUS signals from the circumference of the
phantom were detected at all imaging speeds. The imaging speed did not affect detection
sensitivity and IVPA-US co-registration. However, IVPA-US imaging at speeds of 1 and 5 fps
was not able to accurately capture 1.2 Hz pulsatile motion. The speed of 10 fps was acceptable,
but its slow refresh rate was noticeable. However, there was no observable difference among the
speeds of 16, 20, 25 fps in capturing the 1.2 Hz pulsatile motion. Thus, IVPA-US images at low
imaging speeds were subject to distortion from motion artifacts. As contrasting examples, four
consecutive IVPA-US images at 1 fps (Fig. 4.8a), 5 fps (Fig. 4.8b), 10 fps (Fig. 4.8c), and 16 fps
(Fig. 4.8d) were used to demonstrate the distortion. At lower imaging speeds, there was obvious
A-line signal mismatch at 6 o’clock, where the first and final A-lines in a cross-sectional image
were located (e.g. Frames #2 and #4 in Fig. 4.8a, Frames #2 and #3 in Fig. 4.8b, Frame #4 in Fig.
4.8c). However, at 16 fps, the mismatch became negligible (Fig. 4.8d). Furthermore, the overall
shape of shrink tube at lower speeds was distorted, especially for images at speeds of 1 and 5 fps
(e.g. Frames #1-4 in Fig. 4.8a, Frames #2 and #3 in Fig. 4.8b); while the distortion was
successfully suppressed at 16 fps and its images reflected the real tube cross-sections (Fig. 4.8d).
Lastly, at 16 fps, the dynamic change on tube shape from Frame #1 to #4 in Fig. 4.8d was
continuous; but, at 1 fps, such continuity was not shown (Fig. 4.8a). Thus, a 16 fps imaging
speed should be sufficient to avoid motion artifacts induced by cardiac pulsation for in vivo
IVPA-US imaging.
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Figure 4.8: IVPA-US imaging of pulsatile motion at different speeds. Four consecutive IVPAUS frames selected at speed of (a) 1 fps, (b) 5 fps, (c) 10 fps, and (d) 16 fps highlighting the
imaging distortion induced by pulsatile motion at lower imaging speed, while demonstrating the
capability to suppress the motion artifacts at 16 fps. Complete comparison of IVPA-US imaging
results at different imaging speed (1, 5, 10, 16, 20, and 25 fps) can be found in Supplementary
Video S3. The depth field of view is 5.09 mm. Scale bar: 1 mm.
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4.3.3

IVPA-US imaging of tissue phantom at 16 frames per second

Figure 4.9: IVPA-US imaging of tissue phantom at 16 fps. (a) Picture of tissue phantom. F,
intramuscular fat; T, tendon; M, muscle. Cross-sectional (b) IVPA, (c) IVUS, and (d) merged
images of the tissue phantom. The scale bar and the coordinates in (b) is also applied to (c) and
(d). (e) 3-D rendering method. 3-D rendered (f) IVPA, (g) IVUS, and (h) merged images of the
tissue phantom with a pullback length of 10 mm. The coordinates in (f) is also applied to (g) and
(h). Scale bar: 1 mm.
To test the chemical specificity of our imaging system, we imaged different tissue components,
including intramuscular fat, tendon, and muscle tissue, at 16 fps. Intramuscular fat is rich in CH2
groups and has similar optical absorption at 1.7 µm as intravascular lipids, thus was used to
mimic a lipid-laden plaque. Tendons and muscle tissue were used to mimic the medial layer of
an artery, which is composed of vascular smooth muscle cells and collagen-rich extracellular
matrix. These tissue components were harvested from a swine and dissected into small segments
to be embedded into 2.5% agar gel as shown in Fig. 4.9a. A central lumen was created in the
phantom to insert the imaging catheter and the phantom was submerged in heavy water during
the experiment. A 10 mm pullback of the phantom was captured at 16 fps with a pulse energy of
60 µJ (30.69 mJ/cm2 for laser fluence, calculation found in Fig. 4.4) on the sample and a
pullback speed of 0.5 mm/s. In the pullback, 320 frames of IVPA and IVUS data were acquired
and reconstructed. Figure 4.9b-d showed the IVPA, IVUS, and merged images at one selected
position, respectively. The image frames were 3-D rendered along the pullback direction (3-D
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rendering method was shown in Fig. 4.9e), showing the overall spatial distribution of each
imaged tissue component (Fig. 4.9f-h). In the IVPA channel, only intramuscular fat generated
signal, with a signal-to-noise ratio of 46.8 (Fig. 4.9f). However, in the IVUS channel, all three
tissue components generated similar levels of signal. Thus, these results validated the chemical
selectivity of our imaging system, indicating that lipid deposition in an artery can be specifically
mapped.
4.3.4

IVPA-US imaging of human coronary atherosclerosis

To further validate the imaging system for the detection of lipid-laden plaques, a diseased human
coronary artery was imaged ex vivo. The right coronary artery was dissected from a human heart,
collected from a 44-year old male who died of atherosclerotic hypertensive cardiovascular
disease (gross image was shown in Fig. 4.10a). The artery sample was pressure-fixed in 10%
w/v formalin and immobilized in a Sylgard tray with metal pins and submerged in heavy water
as shown in Fig. 4.10b. A protective polyimide sheath was used to enclose the IVPA-US catheter
except for the imaging window at the catheter tip. The catheter and sheath were inserted to the
artery lumen for IVPA-US imaging at 16 fps and with a pulse energy of 80 µJ (40.93 mJ/cm2 for
laser fluence) on the sample, which is below the 1.0 J/cm2 ANSI safety standard for skin exposed
in 1.7 µm laser [75]. A positive region of interest was identified based on IVPA, IVUS, and
merged images in Fig. 4.10c-e, which was further marked with a metal pin as shown in Fig.
4.10b. There were two sites of lipid deposition at the 2 and 8 o’clock positions, as recognized by
strong signals in the IVPA channel (Fig. 4.10c). There was a noticeable lipid-rich core at the 2
o’clock position, which correlated with luminal encroachment observed in the IVUS channel
(Fig. 4.10d). The co-registered IVPA-US image (Fig. 4.10e) suggested that this lipid-rich core
was beneath a fibrous cap of the plaque surface shown by signal in the IVUS channel. To
validate our imaging results, we performed gold-standard histopathology at the region of interest.
Figure 4.10f provided an overall image of histology. The lumen and artery structure in the
histological section correlated with artery morphology as shown in the IVUS channel.
Furthermore, the areas between 5 and 9 o’clock was rich in fibrous tissue, correlating with the
strong echogenicity observed in the IVUS channel at the same location. Also apparent were two
lipid-rich necrotic cores (Fig. 4.10g,h), as identified by the loss of matrix, cholesterol clefts, and
macrophage infiltration into the lipid pool with an overlying fibrous cap (200 µm thickness).
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Based on these histological hallmarks, we identified this plaque as an advanced fibroatheroma,
which showed strong correlation with our imaging results.
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Figure 4.10: IVPA-US imaging of human coronary atherosclerosis at 16 fps with comparison to
histopathology. (a) Picture of collected human heart. (b) Scenario picture of ex vivo IVPA-US
imaging of dissected human coronary artery. The region of interest was marked by metal pin.
The catheter and sheath were inserted into the artery lumen. Cross-sectional (c) IVPA, (d) IVUS,
and (e) merged images of human coronary artery at the region of interest. (f) Gold-standard
histopathology stained with Movat’s pentachrome at the region of interest. (g)-(h) Magnified
images of lipid deposition sites corresponding to the dashed boxes in (f). * indicates the
accumulation of cholesterol clefts.

55
4.4

Conclusions and discussion

In summary, we have demonstrated a real-time IVPA-US imaging system for the detection of
lipid-laden plaque in a human coronary artery at 16 fps. In this system, we presented several key
innovations, including excitation laser source, fiber-optic rotary joint assembly, 1 mm diameter
IVPA-US catheter, and real-time image processing and display algorithms. By imaging pulsatile
motion at different imaging speeds, 16 fps was determined to be adequate to suppress motion
artifacts from cardiac pulsation for future in vivo applications. Using this system, we further
imaged and identified a lipid-laden plaque ex vivo in a human coronary artery, which was
confirmed by gold-standard histopathology. Collectively, this work offered significant advances
towards the clinical translation of IVPA-US imaging technology.
Imaging speed has been a remaining challenge in development of IVPA/US imaging
technology, primarily limited by laser pulse repetition rate. In this work, we overcame this
obstacle by using a MOPA-pumped OPO with a 2 kHz optical excitation and achieved up to 25
fps imaging speed, making the IVPA-US system comparable to the commercial IVUS and NIRSIVUS systems. Although a video-rate speed at 30 fps is preferred for in vivo applications,
achieving so would potentially be cost-prohibitive during laser sourcing and development.
Moreover, our imaging results concluded that 16 fps imaging speed does not suffer from motion
artifacts induced by cardiac pulsation. Meanwhile, this speed was achieved without significantly
compromising image quality with the reciprocal reduction of number of A-lines per image frame.
To further improve the IVPA imaging quality at 16 fps, we can use a number of strategies
including slightly increasing the laser repetition rate (but number of A-lines does not necessarily
to be the same as that in IVUS channel) or using less A-lines per image frame paired with
advanced reconstruction algorithms that exploit speckle differences in PA and US imaging [99].
Real-time imaging capability is also a critical feature for clinical translation of the IVPAUS technology. It can provide operator the necessary and timely feedback to adjust imaging
parameters based on their operational requirements. These include the laser pulse energy, the
amplification of signals, the pullback speeds, and the image processing parameters. Moreover,
the real-time imaging allows to accurately locate the catheter tip at the time of imaging and
instantly revisit an identified region of interest. The high-speed real-time imaging capability,
along with the superior chemical selectivity and high scalability of PA imaging, makes the
imaging system versatile for other intravascular and endoscopy applications. By using a different
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excitation wavelength or multiple wavelengths, our system could be used to detect other plaque
components, e.g. intraplaque hemorrhage or loss of collagen in the fibrous cap. Furthermore,
exogenous contrast agents could be employed to target other markers of plaque vulnerability
such as macrophage infiltration or matrix metalloproteinases [100-102]. Our system may also
resolve the current limitations (slow imaging speed, 4 Hz; partial field of view) encountered in
PA endoscopy of gastrointestinal tracts [103].
Our system is currently limited by the lack of an optically and acoustically transparent
sheath fully enclosing the IVPA-US imaging catheter. A sheath is a necessary component in a
clinical setting to protect the catheter components and the artery endothelium. In addition, the
sheath must be flexible and have a clinically compatible size. Lastly, a clinically relevant animal
model of atherosclerosis will be critical in refining the catheter and the sheath designs and
preclinical validation of the technology in vivo.
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5. IN VIVO REAL-TIME INTRAVASCULAR PHOTOACOUSTIC
IMAGING OF RABBIT AND SWINE MODELS

Abstract: Atherosclerosis is a leading cause of death in developed countries. Lipid content plays
an important role in determining the vulnerability of an atherosclerotic plaque to rupture. Here,
we present in vivo intravascular photoacoustic (IVPA) tomography for quantitative assessment of
lipid content within and surrounding an arterial wall. By converting laser absorption into
detectable ultrasound waves, IVPA tomography is uniquely capable of assessing the entire
arterial wall with chemical selectivity and depth resolution. Critical improvements of IVPA
technology in this work, including vastly improved catheter sensitivity, functional catheter
sheath selection, and development of a portable high-speed IVPA imaging system, enabled realtime in vivo mapping of lipid content in aortas of New Zealand White rabbits and iliac arteries of
Ossabaw miniature swine at imaging speeds up to 16 frames per second. This work has shown
the clinical significance and translational capability and will pave the foundation for preclinical
and clinical studies of lipid-laden plaque development and treatment.

5.1

Introduction

Cardiovascular disease is the leading cause of mortality in most developed countries and roughly
accounts for a third of all deaths worldwide [104]. This burden is expected to continue to
increase, with coronary artery disease as the major contributor to all cardiovascular diseaserelated deaths. Coronary artery disease refers to the pathologic development of atheromatous
plaques in the coronary arterial tree and the subsequent narrowing of the lumen or even
formation of thrombus due to plaque rupture, leading to restriction of blood flow and lifethreatening acute coronary syndrome [105]. Plaques that are considered most susceptible to
rupture are those with a large lipid-rich necrotic core, covered by a thin fibrous cap, and dense
inflammatory infiltrate [6, 106]. This subset of plaques, referred to as vulnerable plaques, are
challenging to identify in patients as they are often non-obstructive to moderately obstructive,
thus evade routine detection on stress testing and coronary X-ray angiography. Reliable and
accurate detection of vulnerable plaques require not only morphological information of the artery
wall, but also chemical composition of the suspected lesion [107]. Thus, chemical-based
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mapping of lipids in the artery wall can provide valuable information for determining plaque
vulnerability.
A number of cardiovascular imaging modalities, both non-invasive and invasive,
currently exist for the identification of atherosclerotic plaques. Modalities such as X-ray
angiography, magnetic resonance angiography, and computed tomography angiography are
considered lumenographic techniques. Thus, while advantageous in detecting severely stenotic
lesions, they miss vulnerable plaques, which are often positively remodeled and non-flow
limiting [10]. Intravascular ultrasound (IVUS) provides important morphological information of
an artery including luminal geometry, plaque burden, and vascular remodeling [108]. However,
the lack of chemically-selective contrast for soft tissue components prevents IVUS from
providing information on plaque composition [109]. Intravascular optical coherence tomography
provides unmatched spatial resolution for the detection of fibrous cap thickness [81], but lacks
chemical selectivity and sufficient imaging depth to visualize the entire artery wall [19].
Recently, near-infrared spectroscopy combined with IVUS has been shown to detect the
presence of lipid-rich plaques and quantify them with a lipid core burden index, with preliminary
evidence suggesting prognostic value [110, 111]. However, without depth resolution, nearinfrared spectroscopy is not able to provide critical information on the size and quantity of
cholesterol accumulation in lipid-rich plaque cores. Near-infrared fluorescence lifetime imaging
has been applied to resolve chemical composition of an artery wall [112], however, with imaging
depth limited to a very thin layer on the luminal surface.
Intravascular photoacoustic (IVPA) tomography is an emerging technique for the
localization, quantification, and characterization of lipid deposition while simultaneously
complementing IVUS imaging. IVPA utilizes an excitation laser pulse that is delivered to the
arterial wall through an optical fiber via lumen of the artery. Optical absorption by lipid content
in the arterial wall is converted into localized heating and then ultrasonic waves, which are
detected by a transducer installed in the catheter tip, i.e. the photoacoustic effect. A delayed
ultrasound pulse is sent to the arterial wall and its echo is received by the same transducer to
provide an inherent IVUS modality in complement to IVPA imaging. Optical absorption-based
contrast enables chemical selective imaging, while diffused photon excitation and ultrasound
detection in IVPA result in greatly improved imaging depth up to ~5 mm [76, 87]. Catheterbased IVPA imaging integrates optical excitation components and ultrasound pulsing/receiving
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units within a miniaturized imaging probe, ultimately processed to display to the operator the coregistered cross-sectional photoacoustic and ultrasound images of an artery [83]. Development of
IVPA imaging has accelerated in the past several years, including variation of catheter design
[71, 72, 76, 82, 88], development of laser sources for increased lipid sensitivity and imaging
speed [68, 71, 93, 97, 113], and differentiation of multiple tissue components [66, 114, 115].
Nevertheless, technical challenges have prevented the use of IVPA for in vivo demonstration and
future preclinical and clinical studies [69, 70, 85, 116].
Here, enabled by several key technical innovations, we report the first in vivo real-time
IVPA imaging of native arteries in multiple animal models in the presence of luminal blood. We
present quantitative localization and characterization of lipid content along the full depth of the
arterial wall from intima to perivascular adipose tissue for a pullback length and imaging speed
up to 80 mm and 16 frames per second (fps), respectively.

5.2

Methods and materials

5.2.1

IVPA tomography system

The high-speed IVPA tomography system developed by our group provided dual-modality
intravascular photoacoustic and ultrasound imaging at speed up to 16 fps with real-time display
(Fig. 5.1). A 10-ns high-power (up to 2 W) OPO with 2-kHz repetition rate at 1730 nm was
employed as excitation laser source. Pulsed laser beam was coupled to the imaging catheter via a
365-µm-core multimode fiber (FG365LEC, Thorlabs, Inc.). A self-designed and -fabricated
hybrid optical and electrical rotary joint provided highly efficient optical coupling and
radiofrequency signal transmission at fast rotation. Motorized rotational and linear translational
stages (X-NMS17C-E01 & X-LRM100A, Zaber Technologies, Inc.) control the rotation and
pullback of the catheter. A self-designed and -assembled quasi-collinear IVPA catheter with
outer sheath served for the high-sensitivity intravascular PA/US imaging. Delayed (5 µs in this
work) ultrasound pulses triggered by a pulse generator (Model 9512, Quantum Composers, Inc.)
were sent/received by a pulser/receiver (5073PR, Olympus, Inc.). A computer with 500-MS/s 12bit DAQ card (ATS9350, AlazarTech, Inc.) was used for control, processing, real-time display,
and data collection. The entire system was installed in a portable cart for easy transportation (Fig.
5.1b).
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Figure 5.1: Schematic and key components of the IVPA imaging system. (a) Schematic setup of
the IVPA imaging system. (b) Photograph of the portable IVPA system. (c) Photograph of the
hybrid rotary joint and motorized stages. (d) Photograph of the quasi-collinear IVPA catheter
with sheath.
The quasi-collinear IVPA catheter used in the imaging system is composed of a 365-µmcore multimode fiber (FG365LEC, Thorlabs, Inc.) for high-power laser pulse delivery, a fiberend mirror with 600 µm diameter polished to 45° and coated with gold for optical reflection, a
single-element transducer (0.5×0.6×0.2 mm3) with center frequency of 42 MHz and bandwidth
of 50% for ultrasound pulsing and detection (AT23730, Blatek Industries, Inc.), a 3D printed
plastic housing (Proto Labs) for precision positioning of each component, a metal housing to
protect the catheter tip, a 1.2 mm torque coil for twist transmission to the catheter tip, an entire
sheath with PU imaging window for catheter protection and luer-slip connector for fluid flushing
in the catheter (Fig. 5.1d). The transducer was positioned next to the rod mirror and tilted with
10° for quasi-collinear photoacoustic detection, resulting in an estimated depth range of 0.6-6
mm by simple geometrical calculation considering the size of components and reasonable
divergence angles of optical beam (6°) and ultrasound wave (3°). The coupling fiber was
equipped with a FC fiber connector and electrical wire was terminated with a miniature co-axial
connector to be coupled to the hybrid rotary joint. The sheath was sealed at the distal end with a

61
small opening to allow for flushing of the catheter. The diameter of the catheter tip with sheath
was measured to be 1.6 mm.
5.2.2

Data acquisition and processing

The generated photoacoustic and ultrasound signals were digitized by a 500-MS/s 12-bit DAQ
card with external trigger output by the laser source. For real-time display, the sampling rate was
reduced to 250 MS/s and only signals fitting an observation depth of 5 mm were retained for
processing. A 1D despeckle filter was applied along the lateral direction to remove noise induced
by the laser or environment. Signals were then bandpass filtered with proper parameters (2-40
MHz for photoacoustic and 10-50 MHz for ultrasound) and Hilbert transformed to form an
intensity map. A coordinate transform was applied to the intensity map to display the images in
Cartesian coordinates with predefined pixel density, for example 80 pixels per mm in this work.
Log compression was applied to photoacoustic and ultrasound intensity images to provide
improved contrast. For imaging speed of 16 fps, the number of A-lines for ultrasound crosssections was doubled (250 A-lines vs. 125 A-lines for photoacoustic) to increase the data density
of ultrasound image for better artery morphology [93]. Data acquisition, processing, and image
display were enabled via a LabView program. Offline data processing included 3D
reconstruction of both photoacoustic and ultrasound images from their cross-sectional image
stacks.
5.2.3

Lipid quantification

The maximum photoacoustic intensity along the radial direction and the corresponding depth
from the catheter center were calculated for each frame (Fig. 5.2a-c) to generate 2D distribution
maps of lipid (Fig. 5.2d,e) to indicate the lipid concentration and depth in the artery. A binary
lipid index image (i.e. 0 for background and 1 for lipid) was generated by applying a predefined
threshold (4 times of background noise in this work) to the photoacoustic images (Fig. 5.2f). The
angular ratio of maximum lipid pool at each depth, i.e. angle of field of view over 2π, was
generated for every frame (Fig. 5.2g,h) and plotted for the entire pullback length (Fig. 5.2i) to
give complementary information about the lipid core size and depth. The lipid area in each frame
was calculated based on the binary lipid index image and plotted against the pullback length to
visualize the total lipid deposition longitudinally (Fig. 5.2j).
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Figure 5.2: Procedure for lipid quantification and localization. (a) 2D cross-sectional
photoacoustic image was reconstructed from the raw data. (b,c) Peak amplitude of photoacoustic
signal along the radial direction was detected and the corresponding depth was recorded for each
frame. (d,e) Peak amplitude of photoacoustic signal and depth were expressed as 2D images for
the entire pullback to indicate lipid distribution and depth. (f) A proper threshold (4 times of
noise level in this work) was applied to photoacoustic image to generate a cross-sectional binary
lipid map (i.e. 0 for background and 1 denotes lipid presence). (g) Lipid presence along angular
direction at a specific depth was plotted to the show the angle of view for lipid pools. (h) The
angular ratio of the largest lipid pool, i.e. angle of view over 2π in percentage, was generated for
each depth. (i) A map of angular ratio of largest lipid pool was produced along the longitudinal
direction of the artery to provide a complementary information about the lipid pool size and
distribution depth. (j) the total lipid area for each cross-section was quantitated from (f) for the
entire artery.
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5.2.4

Procedure for in vivo IVPA imaging of rabbit aorta

Aorta/'

Figure 5.3: Surgical procedure for in vivo IVPA imaging of a NZW rabbit. (a) 6 Fr introducer
sheath was used to access the left femoral artery for catheterization. (b) Plan for in vivo IVPA
imaging of rabbit aorta with a pullback length of 80 mm. (c) X-ray angiogram indicating the
catheter position inside the rabbit aorta. (d) Imaged aorta segment was excised for histology.
This protocol was performed according to the Animal Studies for Cardiovascular and Intestinal
Imaging and approved by the Purdue Animal Care and Use Committee. Three male NZW rabbits,
aged eight months old, were used for in vivo IVPA imaging. Rabbits were fed with a normal
chow diet prior to imaging and euthanasia. Before imaging procedure, the rabbit was
anesthetized with a proper dose of ketamine (35 mg/kg) and xylazine (5-10 mg/kg) through ear
vein injection and maintained on 1-5% isoflurane mixed with 100% O2 via endotracheal
intubation during the entire imaging process. A cutdown procedure was used to identify the left
femoral artery for intravascular access. A 6 Fr introducer sheath was inserted in the femoral
artery, through which the IVPA catheter was advanced to the thoracic aorta (Fig. 5.3a,b). X-ray
angiograms without contrast were captured to record the location of the catheter tip, aided by
hemostatic forceps clamped externally on the body (Fig. 5.3c). To reduce optical loss and
remove laser heating, the IVPA catheter sheath was flushed with D2O prior to and during
imaging. Different rotational and pullback speed combinations (4 fps and 0.25 mm/s, 16 fps and
1 mm/s) were used to confirm the reproducibility of our imaging system. A total length of 80
mm was recorded for each pullback. Following imaging, the rabbit was euthanized by using
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intravenous euthanasia solution (390 mg/ml) and the aorta was harvested for histology (Fig.
5.3d).
5.2.5

Procedure for in vivo IVPA imaging of swine iliac artery
Aorta

b

Iliac a.

Femoral a.

IVPA

introducer
sheath

Figure 5.4: Pig iliac artery and plan for IVPA imaging. (a) Right iliac arterial tree of a pig and
IVPA imaging plan showing a catheterization via femoral artery and pullback length of 80 mm
starting at iliac artery. (b) Photograph of the imaged iliac and femoral artery after pig euthanasia.
This protocol was performed per the Guide for the Care and Use of Laboratory Animals and
approved by the Indiana University School of Medicine Animal Care and Use Committee.
Ossabaw miniature swine were maintained to meet the characteristics of metabolic syndrome for
eight months, seven of which they were fed a hypercaloric, atherogenic diet (1 kg/day), and aged
approximately 16 months at the time of euthanasia. Metabolic data, including total body weight,
blood pressure, fasting glucose, and lipid panel, were collected to confirm the development of
metabolic syndrome and dyslipidemia. Anesthesia was induced via intramuscular injection of
telazol (5-6 mg/kg) and xylazine (2.2 mg/kg) and maintained on 2-4% isoflurane mixed with 100%
O2, with the level adjusted to maintain stable heart rate and rhythm and blood pressure. After
gaining femoral access via cutdown, a 7 Fr introducer sheath was inserted in the right femoral
artery for intravascular access and heparin was administered (50 U/kg). Aorto-ilio-femoral
anatomy was visualized with X-ray angiography with contrast. The IVPA catheter was advanced
80 mm distal to the introducer sheath and visualized with X-ray angiography without contrast
(Fig. 5.4a). The catheter was flushed with D2O and pullback was recorded at 8 fps and 0.5 mm/s
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for a total length of 80 mm. Following repeat imaging, the swine was euthanized by cardiectomy
and isoflurane overdose. The imaged iliac and femoral artery was harvested for histology (Fig.
5.4b).
5.2.6

Histology approaches

Before excising the artery, sutures were tied at the most distal imaging location, identified either
by measurement from the introducer sheath which served as the proximal imaging marker or reinserting a catheter wire the exact distance the imaging catheter was advanced during imaging
and manually feeling for it lightly. This ensured that for every pullback, two extreme boundaries
were located and marked which reflect the true in vivo imaging distance. This allowed us to
reconcile for the shortening of the arteries (aorta and iliac) after excision due to their elastic
nature. All arteries were pressure fixed in 10% w/v formalin at approximately 25 mL/min for 30
minutes to maintain lumen as close to in vivo morphology as possible. The arteries were then
grossly sectioned in 3-4 mm segments. Next, segments were paraffin embedded, sectioned, and
stained for Verhoeff-van Gieson. Digital images were captured for all slides. To account for
tissue shrinkage from the in vivo length, we used the relative position from the extreme
boundaries (i.e. the initial imaging start and stop positions marked with suture or identified with
the introducer sheath) to approximate the corresponding in vivo frames.

5.3

Results

5.3.1 Clinically relevant IVPA tomography system
Figure 5.5a shows a schematic principle of our IVPA tomography system. Briefly, a Nd:YAG
pumped optical parametric oscillator (OPO) emitting ~10-ns pulse with 2-kHz repetition rate at a
wavelength of 1730 nm served as the excitation laser source. The laser beam was coupled to the
imaging catheter via a multimode fiber and then side-fired to the arterial wall for lipid-specific
excitation. The generated photoacoustic waves from the imaged tissue were received by an
ultrasound transducer installed at the catheter tip location from where the optical pulse was
initially delivered. Simultaneously, a delayed ultrasound pulse was sent and its echo was
received by the same transducer for co-registered IVUS imaging. The dual-modal imaging
catheter was rotated at speed up to 16 revolutions per second and pulled back up to 1 mm/s in a
protective
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photoacoustic/ultrasound (PA/US) images were displayed on screen for real-time interpretation
by the operator. A lipid-specific imaging wavelength of 1730 nm was used owing to the strong
absorption peak of the first vibrational overtone transition of C-H bond, which is abundant in
lipids, and the absorption valley of water in this spectral range (Fig. 5.5c) [39, 67]. Although the
difference in absorption coefficients of lipid and water at 1730 nm is not very distinct, the
generated photoacoustic signal from lipid versus water is substantial due to the greater Gruneisen
parameter of lipid [36], allowing for ample contrast. A representative reconstructed 3D PA/US
image is provided in Fig. 5.5d.
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Figure 5.5: Illustration of intravascular photoacoustic (IVPA) imaging. (a) Implementation of
IVPA imaging. Optical pulses from the excitation laser are coupled to the imaging catheter
through a multimode fiber and a rotary joint. The output optical beam is reflected to the arterial
wall by a rod mirror for photoacoustic excitation. The generated sound wave from optical
absorption is collected by an embedded transducer in the catheter tip. Simultaneously, a delayed
ultrasonic pulse is delivered and its echo is received by the same transducer to produce a coregistered ultrasound image. The rotational and pullback stages are used to constantly rotate and
linearly pull back the IVPA catheter inside a protective sheath for 3D imaging. The reconstructed
photoacoustic (PA) and ultrasound (US) images are displayed on a monitor in real time. (b)
Photograph of the IVPA catheter probe region within a transparent sheath. The diameter of the
catheter including the sheath is 1.6 mm. (c) Absorption spectra of water and lipid in the nearinfrared range. The excitation laser wavelength of 1730 nm is selected to target the first
vibrational overtone absorption peak of C-H bond, abundant in lipids. (d) A representative
reconstructed 3D PA (red hot) and US (gray) merged image of a human coronary artery
produced by our imaging system.
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Figure 5.6: Evaluation of different polymer tubing serving as a sheath material for the IVPA
catheter. Heat-shrink tubing with a diameter of ~4 mm serves as the imaging target due to its
strong photoacoustic signals attributed to the compositions of polyolefin and black carbon. The
catheter rotates inside the sheath to obtain PA/US images of the target. (a) The bare catheter
without a sheath serves as a control. (b-f) Imaging results for sheath material candidates. Both
imaging target (T) and induced artifacts (A) by the sheath are indicated in the merged PA/US
images. FEP: fluorinated ethylene propylene, PTFE: polytetrafluoroethylene, PI: polyimide, PE:
polyethylene, PU: polyurethane. The scale bar is 1 mm. There are notable ultrasound artifacts for
FEP, PTFE, and PI (b-d). Notable photoacoustic artifact is observed for PE (e).
The key component of the IVPA imaging system is the dual-mode PA/US imaging
catheter, which provides high-sensitivity intravascular tomographic images of lipid content
distribution and artery morphology. We previously reported a collinear design [76] for increased
overlap efficiency of the optical beam and acoustic wave. For in vivo applications, we found the
sensitivity in this design is insufficient due to the loss of ultrasound signal at the multiple
reflective surfaces. To improve sensitivity, we developed a quasi-collinear catheter design (Fig.
5.5b and Fig. 5.7a). Briefly, the optical beam was reflected by a 45° rod mirror for side firing.
For safety, the output pulse energy from the catheter tip was controlled below 100 µJ,
corresponding to a laser fluence of 50 mJ/cm2 and below the ANSI laser safety standard of 1
J/cm2 at 1730 nm. Ultrasonic waves were sent directly to the tissue and received by the
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transducer without any redirection, thus preventing signal loss on reflective surfaces. The
transducer was designed to be tilted by 10° and closely positioned with the rod mirror to
maximize the overlap between side-fired optical beam and ultrasonic wave, resulting a quasicollinear overlap covering a depth from 0.6 mm to 6 mm estimated from the geometry and
relative positions of catheter components with consideration of a reasonable divergence of both
optical and acoustic waves (Fig. 5.7a, and Methods), and to reduce the multiple ultrasound
reflection from the protective sheath. The spatial resolution and imaging depth of the catheter
with protective sheath was evaluated by imaging a 7-µm carbon fiber placed at several different
distances from the probe. To maintain a detectable photoacoustic signal for a small target, the
experiments were performed in deuterium oxide (D2O) to reduce optical attenuation in the
medium. The axial resolutions ranged from 83 to 105 µm, while the lateral resolutions increased
from 170 to 450 µm, attributed to the divergence of the ultrasound propagation (Fig. 5.7b). The
photoacoustic intensity followed the expected overlap tendency between optical beam and
ultrasonic wave and was detectable within a depth range from 1.4 to 4.6 mm, sufficient to cover
the entire arterial wall.
Another critical advancement for in vivo applications is the implementation of an outer
sheath for the IVPA catheter. An outer sheath is essential for intravascular imaging and has many
roles, which include prevention of endothelial damage from high-speed catheter rotation and
protection of the catheter components from mechanical damage due to blood, thrombus, or the
catheterization procedure. An optimal IVPA sheath material should be optically and acoustically
transparent, to reduce attenuation of photoacoustic and ultrasound signals to a minimum. We
evaluated the optical and acoustic properties of a number of candidate sheath materials, with
consideration of their biosafety as well, for compatibility with our IVPA catheter by imaging a
heat-shrink tubing (Fig. 5.6). We found fluorinated ethylene propylene, polytetrafluoroethylene,
and polyimide all induced significant ultrasound artifacts compared to images without a sheath,
while polyethylene induced a significant photoacoustic artifact and also greatly attenuated the
transmitted optical power as it has abundant in C-H bonds (Fig. 5.6 and Fig. 5.8). Polyurethane
(PU) was found to induce less artifact and low transmission loss as compared to other sheath
materials, thus was selected as our material of choice for the sheath in imaging window section.
The performance of the PU sheath was further evaluated by ex vivo imaging of a human coronary
artery in different schemes (Fig. 5.7c-e). The catheter with a D2O-filled PU sheath demonstrated
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comparable or even stronger photoacoustic intensity and moderate ultrasound attenuation as
compared to imaging with the bare catheter in PBS. In other words, the optical loss across the
sheath material was compensated by filling the sheath with D2O, which has a much smaller
absorption coefficient than water at 1.7 µm [67]. Furthermore, IVPA imaging with the PU sheath
in the presence of luminal blood (Fig. 5.7e) demonstrated the capability of our imaging system
for in vivo intravascular imaging without luminal blood flushing or dilution. The following in
vivo imaging experiments were based on the scheme described in Fig. 5.7e.
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Figure 5.7: Design and performance of a quasi-collinear IVPA catheter with a PU outer sheath.
(a) Schematic of quasi-collinear IVPA catheter design showing PA imaging depth ranging from
0.6-6 mm based on estimated divergence angles of 3° and 6° for ultrasound wave and optical
beam, respectively. (b) Measured PA axial and lateral resolutions, and PA amplitude at different
depths from 1.4 to 4.6 mm using a 7-µm carbon fiber as the imaging target. Inset shows a
representative PA image at an axial distance of 4.1 mm. (c-e) Comparative IVPA images of
human coronary artery ex vivo under different schemes: (c) bare catheter without a sheath and
luminal PBS, (d) catheter with D2O-filled PU sheath and luminal PBS, (e) catheter with D2Ofilled PU sheath and luminal blood. The scale bar is 1 mm for all images. PU: polyurethane, PBS:
phosphate-buffered saline.
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Figure 5.8: Evaluation of the sheath material candidates based on Fig. 5.7. (a) Photoacoustic
artifact induced by the sheath. (b) Photoacoustic transmission through the sheath. (c) Ultrasound
artifact incuded by the sheath. (d) Ultrasound transmission through the sheath. PU was selected
as the catheter sheath material for the imaging window due to its small artifacts and moderately
low transmission losses for both photoacoustic and ultrasound signals.

5.3.2

In vivo IVPA imaging of rabbit aorta

To validate the feasibility and performance of our imaging system in vivo, we imaged the
thoracic aorta of three lean, male New Zealand White (NZW) rabbits at 8 months of age. All the
rabbits were fed on normal chow diet prior to imaging and euthanasia. With the aid of X-ray
angiography, the quasi-collinear IVPA catheter with sheath was advanced into the thoracic aorta
of rabbit via femoral access (Fig. 5.9a,b and Fig. 5.3a-c). We recorded in vivo IVPA images of
the aorta with 80-mm pullbacks at different rotational and pullback speeds, up to 16 fps and 1
mm/s, respectively (not shown here). Figure 5.9c-e shows representative cross-sectional
photoacoustic (I), ultrasound (II), and merged (III) images at different positions corresponding to
the distal, upper and proximal sections of thoracic aorta. All images shown in Fig. 5.9 were
collected with an imaging speed of 4 fps and a pullback speed of 0.25 mm/s. The photoacoustic
images show the presence of lipid within the aorta wall (Fig. 5.9c) and perivascularly at depths

71
greater than 4 mm (Fig. 5.9d,e). The ultrasound images provide important morphological
information about the artery, such as luminal area and thickness of artery wall. The
corresponding histology sections are shown in Fig. 5.9c-e(IV). Given the young age and lean
diet of the NZW rabbits, we did not expect to see any vascular pathology and indeed the
histology shows this. The abundance of perivascular adipose tissue agrees with the strong
photoacoustic signals detected peripherally in the corresponding sections (Fig. 5.9d,e).
Reconstructed 3D photoacoustic image alone (Fig. 5.9f) and merged PA/US image (Fig. 5.9g)
with a 20-mm pullback length illustrate the detection and presence of perivascular adipose tissue
at the proximal end of the pullback, close to the femoral artery. We further compared imaging
performance at the same location, with increased rotational and pullback speeds (4 fps and 0.25
mm/s vs. 16 fps and 1 mm/s). Similar results were observed for the detected lipid quantity and
depth along the entire pullback, confirming the reproducibility of our imaging system and
protocol.
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Figure 5.9: In vivo IVPA imaging of a rabbit aorta at 4 fps and 0.25 mm/s pullback speed. (a)
Photograph of rotation-pullback carriage, catheter, and rabbit during the in vivo protocol. (b) Xray angiogram of IVPA catheter in the thoracic aorta, with forceps and ruler to locate the
position of the catheter externally. (c-e) Intravascular PA and US images, and corresponding
Verhoeff-van Gieson stained histopathology at different positions along aorta. Labels I-IV
correspond to PA, US, merged PA/US images, and histopathology, respectively. Scale of 1 mm
applies all panels. (f,g) Reconstructed 3D PA and merged PA/US images, respectively, for a
pullback segment of 20-mm length of the aorta.
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5.3.3

In vivo IVPA imaging of swine iliac artery

To further validate the feasibility and performance of our imaging system in vivo, we imaged the
iliac arteries of obese Ossabaw miniature swine, a large animal model that closely mimics human
atherogenesis when fed a hypercaloric, atherogenic diet [117]. The collinear IVPA catheter [93]
with sheath was advanced 80 mm to the right iliac artery via femoral access (Fig. 5.4a). The iliac
anatomy and distal position of the catheter tip were visualized by X-ray angiography, with and
without contrast, to confirm the catheter location (Fig. 5.10a,b). We visualized and recorded in
vivo IVPA cross-sectional images at 8 fps and a pullback speed of 0.5 mm/s across a total length
of 80 mm. Representative IVPA images at different longitudinal locations are shown in Fig.
5.10e-g, with additional merged PA/US images to illustrate the location of detected lipids in
relation to the vessel lumen. Histology sections at the corresponding locations in Fig. 5.10e,f(III)
agree with our imaging results, indicating the photoacoustic signals are primarily from
surrounding perivascular adipose tissue. In Fig. 5.10g(III), we observed a raised intimal lesion at
6 and 11 o’clock, which corresponds to the locations in which we detected stronger
photoacoustic signals. To visualize the lipid content along the entire artery, we extracted the peak
photoacoustic signals along the radial direction per frame, as well as their corresponding depth
from the center of the catheter, and generated the lipid distribution maps as shown in Fig.
5.10c,d (see detailed information in Methods and Fig. 5.2). The strong photoacoustic signal at
the end of the pullback is an artifact of the introducer sheath and serves as positive control
showing the maximum photoacoustic signal. The consistent presence of photoacoustic signal
along the entire pullback length at almost uniform imaging depths outside the vessel further
confirms that we had primarily detected perivascular adipose tissue. This excess perivascular
adipose tissue and thickened intima at some artery sections (Fig. 5.10g) are likely induced by the
atherogenic diet of the swine. The quantitated lipid area in each frame was obtained and plotted
in Fig. 5.10h along the pullback length (see detailed information in Methods and Fig. 5.2), which
is consistent with the variation pattern in Fig. 5.10c,d.
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Figure 5.10: In vivo IVPA imaging of an Ossabaw swine iliac at 8 fps and 0.5 mm/s pullback
speed. (a) X-ray angiogram with contrast of the arterial tree at the right iliac and femoral region.
(b) X-ray angiogram with the same view as (a) without contrast showing placement of the IVPA
catheter 80 mm distal to the introducer sheath. (c,d) Maximum PA signals at each radial
direction (φ) from 0 to 360° along pullback direction (z) from 0 to 80 mm, and their
corresponding depth from the center of the catheter. (e-g) PA images (I), merged PA/US images
(II), and corresponding Verhoeff-van Gieson stained histopathology sections (III) at individual
locations indicated by dashed color lines in (c,d). The histology sections are not circular due to
lack of pressurization ex vivo. (h) Quantitated lipid area at each frame along the 80 mm pullback
length. 1 mm scale applies to all cross-sectional images and histology sections.
5.4

Conclusions and discussion

IVPA imaging brings forth novel capabilities for the detection of lipid-rich atherosclerotic
plaques and perivascular adipose tissue without displacement or occlusion of blood flow. With
several key advances, we demonstrated in vivo IVPA imaging of rabbit and swine arteries under
clinically relevant conditions, which present a key step towards clinical translation. First, our
custom-designed OPO laser source with 2-kHz repetition rate outputting high-energy pulses at
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1730 nm and data processing algorithm allowed for video-rate imaging in real time. Second, our
quasi-collinear catheter design allowed for lipid mapping across a large imaging depth covering
the entire arterial wall while maintaining high spatial resolution ultrasound. Third, the PU sheath
material demonstrated minimal artifact and transmission loss for both photoacoustic and
ultrasound signals. Integration of these technical innovations has enabled the successful
implementation of our method on multiple animal models in vivo under clinically relevant
conditions. Additionally, the greatly improved depth resolution of IVPA enabled imaging of
perivascular adipose tissue. It is increasingly accepted that atherosclerotic lesions primarily
develop in arteries with perivascular adipose [118] and surgical removal of the adipose encasing
the arteries attenuates atherogenesis [119].
We note that several further improvements are necessary to achieve clinical application.
First, the diameter of our current imaging catheter and sheath needs to be further reduced from
1.6 mm to ~1.0 mm for safe coronary artery access. This can be achieved with a thinner optical
fiber, thinner rod mirror, smaller diameter torque coil, proper housing material to integrate the
components of the catheter tip, and thinner catheter sheath. Second, the sheath material can be
further optimized from more polymer candidates to further improve the imaging quality by
reducing the transmission losses and avoiding unnecessary artifacts from the sheath. Third, a
broadband transducer covering the low-frequency photoacoustic signal (typically in several MHz
range [120]) while maintaining ultrasound resolution needs to be developed for better imaging
quality. In addition, to access human coronary arteries, the sheath design must include guidewire
access for directing the catheter during angiography. Lastly, all materials used for catheter
fabrication should adhere to regulatory control for biosafety. The clinical goals of IVPA imaging
will be within reach by implementing these technical improvements.
The broad goal of IVPA imaging is to provide a foundation for building a multimodal
platform for imaging lipid-laden, vulnerable plaque [121] due to its unique capabilities of
chemical-specific detection and depth resolution of lipids. Significant value of IVPA imaging
may be seen in several areas: 1) characterization of the natural history and progression of
vulnerable plaque; 2) identification of solitary vulnerable plaque to determine the efficacy of
treatment interventions; 3) determination of the efficacy of preventative therapies (e.g. statins) to
reduce lipid-core size [122]. Multimodal IVPA-IVUS imaging could open opportunities beyond
the reach of other intravascular imaging tools [98, 121].
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6. OUTLOOK

The past several years has witnessed the rapid development of IVPA imaging from a
fundamental concept to a miniaturized device for clinical translation. These development spans
endogenous contrast mechanism, laser excitation source, catheter designs, and preclinical
validation. Although encouraging, there are still specific challenges to overcome before its
clinical introduction is feasible. Below, we summarize and discuss these challenges along with
the clinical applications IVPA imaging would enable in the near future.
These challenges for clinical introduction primarily come from the IVPA catheter design
in matching the clinical requirements. First, the diameter of our current imaging catheter with
integrated sheath needs to be further reduced ~1.0 mm for safe coronary artery access. This can
be achieved by further miniaturizing the key optical and acoustic components and reducing the
sheath thickness. Second, the sheath material can be further refined to reduce both optical and
ultrasonic transmission loss. Meanwhile, other functionalities can be integrated onto the sheath
material to meet the interventional practices, e.g. fluid flushing of catheter probe prior imaging
and guide wire access for catheter directing during angiography. Third, a high-sensitivity
broadband ultrasound detector is preferred to further improve IVPA detection sensitivity.
Currently, some pure optical detection methods are emerging to replace the traditional ultrasound
transducers, which are typically bulky and has limited bandwidth and sensitivity. Shaping the
excitation beam by increasing the local laser fluence, e.g. quasi-focusing, also improves the
detection sensitivity. Fourth, the majority of reported IVPA catheters works in acousticresolution mode, so their spatial resolutions can be further improved by increasing acoustic
detection bandwidth. Lastly, all catheter components should adhere to regulatory control for
biosafety. Besides the catheter refinements, higher imaging speed (above 16 fps) is always
preferred when high-repetition-rate laser source is available and operated within the safety limit.
In addition, IVPA imaging sensitivity and specificity for lipid-rich necrotic cores must be
systematically validated through comparison with gold-standard histopathology. Longitudinal
studies of lipid-rich plaque formation can be further performed in these animal models.
Compared with small animal models, large animal models, e.g. pigs, are preferred for IVPA
imaging
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After solid preclinical/clinical validations, IVPA imaging can provide the unmet clinical
need for the detection of atherosclerotic plaques vulnerable to rupture. Based on the imaging
results, proper treatment or prevention strategy can be utilized to a patient. Furthermore, IVPA
imaging can also be a powerful research tool for a number of clinical applications. For example,
it can be used to monitor the plaque formation process so that the role of lipid composition in
atherosclerotic plaque progression or plaque rupture can be further elucidated. Currently, no
methods exist to evaluate the use of lipid-lowering therapies in reducing true lipid core size due
to the lack of in vivo methods to longitudinal monitor lipid content inside the coronary arterial
wall. IVPA imaging can potentially fill this gap by monitoring therapy-induced lipid content
changes, which can be performed in living animals and eventually human patients.
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